<?xml version="1.0" encoding="UTF-8"?><rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns="http://purl.org/rss/1.0/" xmlns:admin="http://webns.net/mvcb/">
<channel rdf:about="http://www.nature.com/onc/journal/vaop/ncurrent/rss.rdf">
<title>Oncogene</title>
<description/>
<link>http://www.nature.com/onc/journal/vaop/ncurrent/rss.rdf</link>
<admin:generatorAgent rdf:resource="http://www.nature.com/"/>
<admin:errorReportsTo rdf:resource="mailto:feedback@nature.com"/>
<dc:publisher>Nature Publishing Group</dc:publisher>
<dc:language>en</dc:language>
<dc:rights> Copyright
                    &#169;  Nature Publishing Group</dc:rights>
<prism:publicationName>Oncogene</prism:publicationName>
<prism:issn>0950-9232</prism:issn>
<prism:copyright> Copyright
                    &#169;  Nature Publishing Group</prism:copyright>
<prism:rightsAgent>permissions@nature.com</prism:rightsAgent>
<image rdf:resource="http://www.nature.com/aj/images/logos_b_o_w/onc.gif"/>
<items>
<rdf:Seq>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/onc.2009.119"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/onc.2009.148"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/onc.2009.159"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/onc.2009.152"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/onc.2009.156"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/onc.2009.101"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/onc.2009.112"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/onc.2009.130"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/onc.2009.163"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/onc.2009.123"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/onc.2009.141"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/onc.2009.170"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/onc.2009.105"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/onc.2009.116"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/onc.2009.134"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/onc.2009.145"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/onc.2009.127"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/onc.2009.174"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/onc.2009.109"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/onc.2009.138"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/onc.2009.149"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/onc.2009.178"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/onc.2009.142"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/onc.2009.153"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/onc.2009.182"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/onc.2009.146"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/onc.2009.120"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/onc.2009.160"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/onc.2009.175"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/onc.2009.131"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/onc.2009.124"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/onc.2009.164"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/onc.2009.135"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/onc.2009.128"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/onc.2009.168"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/onc.2009.139"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/onc.2009.183"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/onc.2009.132"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/onc.2009.147"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/onc.2009.150"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/onc.2009.165"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/onc.2009.136"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/onc.2009.121"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/onc.2009.154"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/onc.2009.118"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/onc.2009.169"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/onc.2009.125"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/onc.2009.158"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/onc.2009.129"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/onc.2009.162"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/onc.2009.122"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/onc.2009.140"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/onc.2009.151"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/onc.2009.133"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/onc.2009.126"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/onc.2009.104"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/onc.2009.115"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/onc.2009.144"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/onc.2009.137"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/onc.2009.155"/>
</rdf:Seq>
</items>
</channel>
<image rdf:about="http://www.nature.com/aj/images/logos_b_o_w/onc.gif">
<title>Oncogene</title>
<url>http://www.nature.com/aj/images/logos_b_o_w/onc.gif</url>
<link>http://www.nature.com/onc/</link>
</image>
<item rdf:about="http://dx.doi.org/10.1038/onc.2009.119">
<title>PAK signaling in oncogenesis</title>
<link>http://dx.doi.org/10.1038/onc.2009.119</link>
<content:encoded><![CDATA[
            
<p>
<b>PAK signaling in oncogenesis</b>
</p>
<p>Oncogene advance online publication, May 25, 2009. <a href="http://dx.doi.org/10.1038/onc.2009.119">doi:10.1038/onc.2009.119</a>
</p>
<p>Authors: P R Molli, D Q Li, B W Murray, S K Rayala
                    &amp; R Kumar</p>
]]></content:encoded>
<dc:title>PAK signaling in oncogenesis</dc:title>
<dc:creator>P R Molli</dc:creator>
<dc:creator>D Q Li</dc:creator>
<dc:creator>B W Murray</dc:creator>
<dc:creator>S K Rayala</dc:creator>
<dc:creator>R Kumar</dc:creator>
<dc:identifier>doi:10.1038/onc.2009.119</dc:identifier>
<dc:source>Oncogene advance online publication, May 25, 2009</dc:source>
<dc:date>2009-05-25</dc:date>
<prism:publicationName>Oncogene</prism:publicationName>
<prism:publicationDate>May 25, 2009</prism:publicationDate>
<prism:doi>10.1038/onc.2009.119</prism:doi>
<prism:url>http://dx.doi.org/10.1038/onc.2009.119</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/onc.2009.148">
<title>Defective expression of polarity protein PAR-3 gene (PARD3) in esophageal squamous cell carcinoma</title>
<link>http://dx.doi.org/10.1038/onc.2009.148</link>
<content:encoded><![CDATA[
            
<p>
<b>Defective expression of polarity protein PAR-3 gene (PARD3) in esophageal squamous cell carcinoma</b>
</p>
<p>Oncogene advance online publication, June 8, 2009. <a href="http://dx.doi.org/10.1038/onc.2009.148">doi:10.1038/onc.2009.148</a>
</p>
<p>Authors: K Zen, K Yasui, Y Gen, O Dohi, N Wakabayashi, S Mitsufuji, Y Itoh, Y Zen, Y Nakanuma, M Taniwaki, T Okanoue
                    &amp; T Yoshikawa</p>
]]></content:encoded>
<dc:title>Defective expression of polarity protein PAR-3 gene (PARD3) in esophageal squamous cell carcinoma</dc:title>
<dc:creator>K Zen</dc:creator>
<dc:creator>K Yasui</dc:creator>
<dc:creator>Y Gen</dc:creator>
<dc:creator>O Dohi</dc:creator>
<dc:creator>N Wakabayashi</dc:creator>
<dc:creator>S Mitsufuji</dc:creator>
<dc:creator>Y Itoh</dc:creator>
<dc:creator>Y Zen</dc:creator>
<dc:creator>Y Nakanuma</dc:creator>
<dc:creator>M Taniwaki</dc:creator>
<dc:creator>T Okanoue</dc:creator>
<dc:creator>T Yoshikawa</dc:creator>
<dc:identifier>doi:10.1038/onc.2009.148</dc:identifier>
<dc:source>Oncogene advance online publication, June 8, 2009</dc:source>
<dc:date>2009-06-08</dc:date>
<prism:publicationName>Oncogene</prism:publicationName>
<prism:publicationDate>June 8, 2009</prism:publicationDate>
<prism:doi>10.1038/onc.2009.148</prism:doi>
<prism:url>http://dx.doi.org/10.1038/onc.2009.148</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/onc.2009.159">
<title>GATA4 is a regulator of astrocyte cell proliferation and apoptosis in the human and murine central nervous system</title>
<link>http://dx.doi.org/10.1038/onc.2009.159</link>
<content:encoded><![CDATA[
            
<p>
<b>GATA4 is a regulator of astrocyte cell proliferation and apoptosis in the human and murine central nervous system</b>
</p>
<p>Oncogene advance online publication, June 22, 2009. <a href="http://dx.doi.org/10.1038/onc.2009.159">doi:10.1038/onc.2009.159</a>
</p>
<p>Authors: S Agnihotri, A Wolf, D Picard, C Hawkins
                    &amp; A Guha</p>
]]></content:encoded>
<dc:title>GATA4 is a regulator of astrocyte cell proliferation and apoptosis in the human and murine central nervous system</dc:title>
<dc:creator>S Agnihotri</dc:creator>
<dc:creator>A Wolf</dc:creator>
<dc:creator>D Picard</dc:creator>
<dc:creator>C Hawkins</dc:creator>
<dc:creator>A Guha</dc:creator>
<dc:identifier>doi:10.1038/onc.2009.159</dc:identifier>
<dc:source>Oncogene advance online publication, June 22, 2009</dc:source>
<dc:date>2009-06-22</dc:date>
<prism:publicationName>Oncogene</prism:publicationName>
<prism:publicationDate>June 22, 2009</prism:publicationDate>
<prism:doi>10.1038/onc.2009.159</prism:doi>
<prism:url>http://dx.doi.org/10.1038/onc.2009.159</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/onc.2009.152">
<title>RASSF2 associates with and stabilizes the proapoptotic kinase MST2</title>
<link>http://dx.doi.org/10.1038/onc.2009.152</link>
<content:encoded><![CDATA[
            
<p>
<b>RASSF2 associates with and stabilizes the proapoptotic kinase MST2</b>
</p>
<p>Oncogene advance online publication, June 15, 2009. <a href="http://dx.doi.org/10.1038/onc.2009.152">doi:10.1038/onc.2009.152</a>
</p>
<p>Authors: W N Cooper, L B Hesson, D Matallanas, A Dallol, A von Kriegsheim, R Ward, W Kolch
                    &amp; F Latif</p>
]]></content:encoded>
<dc:title>RASSF2 associates with and stabilizes the proapoptotic kinase MST2</dc:title>
<dc:creator>W N Cooper</dc:creator>
<dc:creator>L B Hesson</dc:creator>
<dc:creator>D Matallanas</dc:creator>
<dc:creator>A Dallol</dc:creator>
<dc:creator>A von Kriegsheim</dc:creator>
<dc:creator>R Ward</dc:creator>
<dc:creator>W Kolch</dc:creator>
<dc:creator>F Latif</dc:creator>
<dc:identifier>doi:10.1038/onc.2009.152</dc:identifier>
<dc:source>Oncogene advance online publication, June 15, 2009</dc:source>
<dc:date>2009-06-15</dc:date>
<prism:publicationName>Oncogene</prism:publicationName>
<prism:publicationDate>June 15, 2009</prism:publicationDate>
<prism:doi>10.1038/onc.2009.152</prism:doi>
<prism:url>http://dx.doi.org/10.1038/onc.2009.152</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/onc.2009.156">
<title>Alterations of ubiquitin ligases in human cancer and their association with the natural history of the tumor</title>
<link>http://dx.doi.org/10.1038/onc.2009.156</link>
<content:encoded><![CDATA[
            
<p>
<b>Alterations of ubiquitin ligases in human cancer and their association with the natural history of the tumor</b>
</p>
<p>Oncogene advance online publication, June 22, 2009. <a href="http://dx.doi.org/10.1038/onc.2009.156">doi:10.1038/onc.2009.156</a>
</p>
<p>Authors: S Confalonieri, M Quarto, G Goisis, P Nuciforo, M Donzelli, G Jodice, G Pelosi, G Viale, S Pece
                    &amp; P P Di Fiore</p>
]]></content:encoded>
<dc:title>Alterations of ubiquitin ligases in human cancer and their association with the natural history of the tumor</dc:title>
<dc:creator>S Confalonieri</dc:creator>
<dc:creator>M Quarto</dc:creator>
<dc:creator>G Goisis</dc:creator>
<dc:creator>P Nuciforo</dc:creator>
<dc:creator>M Donzelli</dc:creator>
<dc:creator>G Jodice</dc:creator>
<dc:creator>G Pelosi</dc:creator>
<dc:creator>G Viale</dc:creator>
<dc:creator>S Pece</dc:creator>
<dc:creator>P P Di Fiore</dc:creator>
<dc:identifier>doi:10.1038/onc.2009.156</dc:identifier>
<dc:source>Oncogene advance online publication, June 22, 2009</dc:source>
<dc:date>2009-06-22</dc:date>
<prism:publicationName>Oncogene</prism:publicationName>
<prism:publicationDate>June 22, 2009</prism:publicationDate>
<prism:doi>10.1038/onc.2009.156</prism:doi>
<prism:url>http://dx.doi.org/10.1038/onc.2009.156</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/onc.2009.101">
<title>RUNX1 and its fusion oncoprotein derivative, RUNX1-ETO, induce senescence-like growth arrest independently of replicative stress</title>
<link>http://dx.doi.org/10.1038/onc.2009.101</link>
<content:encoded><![CDATA[
            
<p>
<b>RUNX1 and its fusion oncoprotein derivative, RUNX1-ETO, induce senescence-like growth arrest independently of replicative stress</b>
</p>
<p>Oncogene advance online publication, May 18, 2009. <a href="http://dx.doi.org/10.1038/onc.2009.101">doi:10.1038/onc.2009.101</a>
</p>
<p>Authors: K Wolyniec, S Wotton, A Kilbey, A Jenkins, A Terry, G Peters, C Stocking, E Cameron
                    &amp; J C Neil</p>
]]></content:encoded>
<dc:title>RUNX1 and its fusion oncoprotein derivative, RUNX1-ETO, induce senescence-like growth arrest independently of replicative stress</dc:title>
<dc:creator>K Wolyniec</dc:creator>
<dc:creator>S Wotton</dc:creator>
<dc:creator>A Kilbey</dc:creator>
<dc:creator>A Jenkins</dc:creator>
<dc:creator>A Terry</dc:creator>
<dc:creator>G Peters</dc:creator>
<dc:creator>C Stocking</dc:creator>
<dc:creator>E Cameron</dc:creator>
<dc:creator>J C Neil</dc:creator>
<dc:identifier>doi:10.1038/onc.2009.101</dc:identifier>
<dc:source>Oncogene advance online publication, May 18, 2009</dc:source>
<dc:date>2009-05-18</dc:date>
<prism:publicationName>Oncogene</prism:publicationName>
<prism:publicationDate>May 18, 2009</prism:publicationDate>
<prism:doi>10.1038/onc.2009.101</prism:doi>
<prism:url>http://dx.doi.org/10.1038/onc.2009.101</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/onc.2009.112">
<title>c-Myc activates multiple metabolic networks to generate substrates for cell-cycle entry</title>
<link>http://dx.doi.org/10.1038/onc.2009.112</link>
<content:encoded><![CDATA[
            
<p>
<b>c-Myc activates multiple metabolic networks to generate substrates for cell-cycle entry</b>
</p>
<p>Oncogene advance online publication, May 18, 2009. <a href="http://dx.doi.org/10.1038/onc.2009.112">doi:10.1038/onc.2009.112</a>
</p>
<p>Authors: F Morrish, N Isern, M Sadilek, M Jeffrey
                    &amp; D M Hockenbery</p>
]]></content:encoded>
<dc:title>c-Myc activates multiple metabolic networks to generate substrates for cell-cycle entry</dc:title>
<dc:creator>F Morrish</dc:creator>
<dc:creator>N Isern</dc:creator>
<dc:creator>M Sadilek</dc:creator>
<dc:creator>M Jeffrey</dc:creator>
<dc:creator>D M Hockenbery</dc:creator>
<dc:identifier>doi:10.1038/onc.2009.112</dc:identifier>
<dc:source>Oncogene advance online publication, May 18, 2009</dc:source>
<dc:date>2009-05-18</dc:date>
<prism:publicationName>Oncogene</prism:publicationName>
<prism:publicationDate>May 18, 2009</prism:publicationDate>
<prism:doi>10.1038/onc.2009.112</prism:doi>
<prism:url>http://dx.doi.org/10.1038/onc.2009.112</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/onc.2009.130">
<title>Interleukin 6 secreted from adipose stromal cells promotes migration and invasion of breast cancer cells</title>
<link>http://dx.doi.org/10.1038/onc.2009.130</link>
<content:encoded><![CDATA[
            
<p>
<b>Interleukin 6 secreted from adipose stromal cells promotes migration and invasion of breast cancer cells</b>
</p>
<p>Oncogene advance online publication, June 1, 2009. <a href="http://dx.doi.org/10.1038/onc.2009.130">doi:10.1038/onc.2009.130</a>
</p>
<p>Authors: M Walter, S Liang, S Ghosh, P J Hornsby
                    &amp; R Li</p>
]]></content:encoded>
<dc:title>Interleukin 6 secreted from adipose stromal cells promotes migration and invasion of breast cancer cells</dc:title>
<dc:creator>M Walter</dc:creator>
<dc:creator>S Liang</dc:creator>
<dc:creator>S Ghosh</dc:creator>
<dc:creator>P J Hornsby</dc:creator>
<dc:creator>R Li</dc:creator>
<dc:identifier>doi:10.1038/onc.2009.130</dc:identifier>
<dc:source>Oncogene advance online publication, June 1, 2009</dc:source>
<dc:date>2009-06-01</dc:date>
<prism:publicationName>Oncogene</prism:publicationName>
<prism:publicationDate>June 1, 2009</prism:publicationDate>
<prism:doi>10.1038/onc.2009.130</prism:doi>
<prism:url>http://dx.doi.org/10.1038/onc.2009.130</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/onc.2009.163">
<title>Proteinase-activated receptor 2 expression in breast cancer and its role in breast cancer cell migration</title>
<link>http://dx.doi.org/10.1038/onc.2009.163</link>
<content:encoded><![CDATA[
            
<p>
<b>Proteinase-activated receptor 2 expression in breast cancer and its role in breast cancer cell migration</b>
</p>
<p>Oncogene advance online publication, June 22, 2009. <a href="http://dx.doi.org/10.1038/onc.2009.163">doi:10.1038/onc.2009.163</a>
</p>
<p>Authors: S Su, Y Li, Y Luo, Y Sheng, Y Su, R N Padia, Z K Pan, Z Dong
                    &amp; S Huang</p>
]]></content:encoded>
<dc:title>Proteinase-activated receptor 2 expression in breast cancer and its role in breast cancer cell migration</dc:title>
<dc:creator>S Su</dc:creator>
<dc:creator>Y Li</dc:creator>
<dc:creator>Y Luo</dc:creator>
<dc:creator>Y Sheng</dc:creator>
<dc:creator>Y Su</dc:creator>
<dc:creator>R N Padia</dc:creator>
<dc:creator>Z K Pan</dc:creator>
<dc:creator>Z Dong</dc:creator>
<dc:creator>S Huang</dc:creator>
<dc:identifier>doi:10.1038/onc.2009.163</dc:identifier>
<dc:source>Oncogene advance online publication, June 22, 2009</dc:source>
<dc:date>2009-06-22</dc:date>
<prism:publicationName>Oncogene</prism:publicationName>
<prism:publicationDate>June 22, 2009</prism:publicationDate>
<prism:doi>10.1038/onc.2009.163</prism:doi>
<prism:url>http://dx.doi.org/10.1038/onc.2009.163</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/onc.2009.123">
<title>CHFR, a potential tumor suppressor, downregulates interleukin-8 through the inhibition of NF-&#954;B</title>
<link>http://dx.doi.org/10.1038/onc.2009.123</link>
<content:encoded><![CDATA[
            
<p>
<b>CHFR, a potential tumor suppressor, downregulates interleukin-8 through the inhibition of NF-&#954;B</b>
</p>
<p>Oncogene advance online publication, May 18, 2009. <a href="http://dx.doi.org/10.1038/onc.2009.123">doi:10.1038/onc.2009.123</a>
</p>
<p>Authors: L Kashima, M Toyota, H Mita, H Suzuki, M Idogawa, K Ogi, Y Sasaki
                    &amp; T Tokino</p>
]]></content:encoded>
<dc:title>CHFR, a potential tumor suppressor, downregulates interleukin-8 through the inhibition of NF-&#954;B</dc:title>
<dc:creator>L Kashima</dc:creator>
<dc:creator>M Toyota</dc:creator>
<dc:creator>H Mita</dc:creator>
<dc:creator>H Suzuki</dc:creator>
<dc:creator>M Idogawa</dc:creator>
<dc:creator>K Ogi</dc:creator>
<dc:creator>Y Sasaki</dc:creator>
<dc:creator>T Tokino</dc:creator>
<dc:identifier>doi:10.1038/onc.2009.123</dc:identifier>
<dc:source>Oncogene advance online publication, May 18, 2009</dc:source>
<dc:date>2009-05-18</dc:date>
<prism:publicationName>Oncogene</prism:publicationName>
<prism:publicationDate>May 18, 2009</prism:publicationDate>
<prism:doi>10.1038/onc.2009.123</prism:doi>
<prism:url>http://dx.doi.org/10.1038/onc.2009.123</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/onc.2009.141">
<title>BubR1 localizes to centrosomes and suppresses centrosome amplification via regulating Plk1 activity in interphase cells</title>
<link>http://dx.doi.org/10.1038/onc.2009.141</link>
<content:encoded><![CDATA[
            
<p>
<b>BubR1 localizes to centrosomes and suppresses centrosome amplification via regulating Plk1 activity in interphase cells</b>
</p>
<p>Oncogene advance online publication, June 8, 2009. <a href="http://dx.doi.org/10.1038/onc.2009.141">doi:10.1038/onc.2009.141</a>
</p>
<p>Authors: H Izumi, Y Matsumoto, T Ikeuchi, H Saya, T Kajii
                    &amp; S Matsuura</p>
]]></content:encoded>
<dc:title>BubR1 localizes to centrosomes and suppresses centrosome amplification via regulating Plk1 activity in interphase cells</dc:title>
<dc:creator>H Izumi</dc:creator>
<dc:creator>Y Matsumoto</dc:creator>
<dc:creator>T Ikeuchi</dc:creator>
<dc:creator>H Saya</dc:creator>
<dc:creator>T Kajii</dc:creator>
<dc:creator>S Matsuura</dc:creator>
<dc:identifier>doi:10.1038/onc.2009.141</dc:identifier>
<dc:source>Oncogene advance online publication, June 8, 2009</dc:source>
<dc:date>2009-06-08</dc:date>
<prism:publicationName>Oncogene</prism:publicationName>
<prism:publicationDate>June 8, 2009</prism:publicationDate>
<prism:doi>10.1038/onc.2009.141</prism:doi>
<prism:url>http://dx.doi.org/10.1038/onc.2009.141</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/onc.2009.170">
<title>Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms</title>
<link>http://dx.doi.org/10.1038/onc.2009.170</link>
<content:encoded><![CDATA[
            
<p>
<b>Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms</b>
</p>
<p>Oncogene advance online publication, June 29, 2009. <a href="http://dx.doi.org/10.1038/onc.2009.170">doi:10.1038/onc.2009.170</a>
</p>
<p>Authors: A Satyanarayana
                    &amp; P Kaldis</p>
]]></content:encoded>
<dc:title>Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms</dc:title>
<dc:creator>A Satyanarayana</dc:creator>
<dc:creator>P Kaldis</dc:creator>
<dc:identifier>doi:10.1038/onc.2009.170</dc:identifier>
<dc:source>Oncogene advance online publication, June 29, 2009</dc:source>
<dc:date>2009-06-29</dc:date>
<prism:publicationName>Oncogene</prism:publicationName>
<prism:publicationDate>June 29, 2009</prism:publicationDate>
<prism:doi>10.1038/onc.2009.170</prism:doi>
<prism:url>http://dx.doi.org/10.1038/onc.2009.170</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/onc.2009.105">
<title>Upregulation of Eps8 in oral squamous cell carcinoma promotes cell migration and invasion through integrin-dependent Rac1 activation</title>
<link>http://dx.doi.org/10.1038/onc.2009.105</link>
<content:encoded><![CDATA[
            
<p>
<b>Upregulation of Eps8 in oral squamous cell carcinoma promotes cell migration and invasion through integrin-dependent Rac1 activation</b>
</p>
<p>Oncogene advance online publication, May 18, 2009. <a href="http://dx.doi.org/10.1038/onc.2009.105">doi:10.1038/onc.2009.105</a>
</p>
<p>Authors: L F Yap, V Jenei, C M Robinson, K Moutasim, T M Benn, S P Threadgold, V Lopes, W Wei, G J Thomas
                    &amp; I C Paterson</p>
]]></content:encoded>
<dc:title>Upregulation of Eps8 in oral squamous cell carcinoma promotes cell migration and invasion through integrin-dependent Rac1 activation</dc:title>
<dc:creator>L F Yap</dc:creator>
<dc:creator>V Jenei</dc:creator>
<dc:creator>C M Robinson</dc:creator>
<dc:creator>K Moutasim</dc:creator>
<dc:creator>T M Benn</dc:creator>
<dc:creator>S P Threadgold</dc:creator>
<dc:creator>V Lopes</dc:creator>
<dc:creator>W Wei</dc:creator>
<dc:creator>G J Thomas</dc:creator>
<dc:creator>I C Paterson</dc:creator>
<dc:identifier>doi:10.1038/onc.2009.105</dc:identifier>
<dc:source>Oncogene advance online publication, May 18, 2009</dc:source>
<dc:date>2009-05-18</dc:date>
<prism:publicationName>Oncogene</prism:publicationName>
<prism:publicationDate>May 18, 2009</prism:publicationDate>
<prism:doi>10.1038/onc.2009.105</prism:doi>
<prism:url>http://dx.doi.org/10.1038/onc.2009.105</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/onc.2009.116">
<title>Ror2, a developmentally regulated kinase, promotes tumor growth potential in renal cell carcinoma</title>
<link>http://dx.doi.org/10.1038/onc.2009.116</link>
<content:encoded><![CDATA[
            
<p>
<b>Ror2, a developmentally regulated kinase, promotes tumor growth potential in renal cell carcinoma</b>
</p>
<p>Oncogene advance online publication, May 18, 2009. <a href="http://dx.doi.org/10.1038/onc.2009.116">doi:10.1038/onc.2009.116</a>
</p>
<p>Authors: T M Wright, A R Brannon, J D Gordan, A J Mikels, C Mitchell, S Chen, I Espinosa, M van de Rijn, R Pruthi, E Wallen, L Edwards, R Nusse
                    &amp; W K Rathmell</p>
]]></content:encoded>
<dc:title>Ror2, a developmentally regulated kinase, promotes tumor growth potential in renal cell carcinoma</dc:title>
<dc:creator>T M Wright</dc:creator>
<dc:creator>A R Brannon</dc:creator>
<dc:creator>J D Gordan</dc:creator>
<dc:creator>A J Mikels</dc:creator>
<dc:creator>C Mitchell</dc:creator>
<dc:creator>S Chen</dc:creator>
<dc:creator>I Espinosa</dc:creator>
<dc:creator>M van de Rijn</dc:creator>
<dc:creator>R Pruthi</dc:creator>
<dc:creator>E Wallen</dc:creator>
<dc:creator>L Edwards</dc:creator>
<dc:creator>R Nusse</dc:creator>
<dc:creator>W K Rathmell</dc:creator>
<dc:identifier>doi:10.1038/onc.2009.116</dc:identifier>
<dc:source>Oncogene advance online publication, May 18, 2009</dc:source>
<dc:date>2009-05-18</dc:date>
<prism:publicationName>Oncogene</prism:publicationName>
<prism:publicationDate>May 18, 2009</prism:publicationDate>
<prism:doi>10.1038/onc.2009.116</prism:doi>
<prism:url>http://dx.doi.org/10.1038/onc.2009.116</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/onc.2009.134">
<title>Frequent loss of cystatin E&#47;M expression implicated in the progression of prostate cancer</title>
<link>http://dx.doi.org/10.1038/onc.2009.134</link>
<content:encoded><![CDATA[
            
<p>
<b>Frequent loss of cystatin E&#47;M expression implicated in the progression of prostate cancer</b>
</p>
<p>Oncogene advance online publication, June 8, 2009. <a href="http://dx.doi.org/10.1038/onc.2009.134">doi:10.1038/onc.2009.134</a>
</p>
<p>Authors: S M Pulukuri, B Gorantla, J A Knost
                    &amp; J S Rao</p>
]]></content:encoded>
<dc:title>Frequent loss of cystatin E&#47;M expression implicated in the progression of prostate cancer</dc:title>
<dc:creator>S M Pulukuri</dc:creator>
<dc:creator>B Gorantla</dc:creator>
<dc:creator>J A Knost</dc:creator>
<dc:creator>J S Rao</dc:creator>
<dc:identifier>doi:10.1038/onc.2009.134</dc:identifier>
<dc:source>Oncogene advance online publication, June 8, 2009</dc:source>
<dc:date>2009-06-08</dc:date>
<prism:publicationName>Oncogene</prism:publicationName>
<prism:publicationDate>June 8, 2009</prism:publicationDate>
<prism:doi>10.1038/onc.2009.134</prism:doi>
<prism:url>http://dx.doi.org/10.1038/onc.2009.134</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/onc.2009.145">
<title>Novel gene C17orf37 in 17q12 amplicon promotes migration and invasion of prostate cancer cells</title>
<link>http://dx.doi.org/10.1038/onc.2009.145</link>
<content:encoded><![CDATA[
            
<p>
<b>Novel gene C17orf37 in 17q12 amplicon promotes migration and invasion of prostate cancer cells</b>
</p>
<p>Oncogene advance online publication, June 8, 2009. <a href="http://dx.doi.org/10.1038/onc.2009.145">doi:10.1038/onc.2009.145</a>
</p>
<p>Authors: S Dasgupta, L M Wasson, N Rauniyar, L Prokai, J Borejdo
                    &amp; J K Vishwanatha</p>
]]></content:encoded>
<dc:title>Novel gene C17orf37 in 17q12 amplicon promotes migration and invasion of prostate cancer cells</dc:title>
<dc:creator>S Dasgupta</dc:creator>
<dc:creator>L M Wasson</dc:creator>
<dc:creator>N Rauniyar</dc:creator>
<dc:creator>L Prokai</dc:creator>
<dc:creator>J Borejdo</dc:creator>
<dc:creator>J K Vishwanatha</dc:creator>
<dc:identifier>doi:10.1038/onc.2009.145</dc:identifier>
<dc:source>Oncogene advance online publication, June 8, 2009</dc:source>
<dc:date>2009-06-08</dc:date>
<prism:publicationName>Oncogene</prism:publicationName>
<prism:publicationDate>June 8, 2009</prism:publicationDate>
<prism:doi>10.1038/onc.2009.145</prism:doi>
<prism:url>http://dx.doi.org/10.1038/onc.2009.145</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/onc.2009.127">
<title>Degradation of cyclin A is regulated by acetylation</title>
<link>http://dx.doi.org/10.1038/onc.2009.127</link>
<content:encoded><![CDATA[
            
<p>
<b>Degradation of cyclin A is regulated by acetylation</b>
</p>
<p>Oncogene advance online publication, June 1, 2009. <a href="http://dx.doi.org/10.1038/onc.2009.127">doi:10.1038/onc.2009.127</a>
</p>
<p>Authors: F Mateo, M Vidal-Laliena, N Canela, L Busino, M A Martinez-Balbas, M Pagano, N Agell
                    &amp; O Bachs</p>
]]></content:encoded>
<dc:title>Degradation of cyclin A is regulated by acetylation</dc:title>
<dc:creator>F Mateo</dc:creator>
<dc:creator>M Vidal-Laliena</dc:creator>
<dc:creator>N Canela</dc:creator>
<dc:creator>L Busino</dc:creator>
<dc:creator>M A Martinez-Balbas</dc:creator>
<dc:creator>M Pagano</dc:creator>
<dc:creator>N Agell</dc:creator>
<dc:creator>O Bachs</dc:creator>
<dc:identifier>doi:10.1038/onc.2009.127</dc:identifier>
<dc:source>Oncogene advance online publication, June 1, 2009</dc:source>
<dc:date>2009-06-01</dc:date>
<prism:publicationName>Oncogene</prism:publicationName>
<prism:publicationDate>June 1, 2009</prism:publicationDate>
<prism:doi>10.1038/onc.2009.127</prism:doi>
<prism:url>http://dx.doi.org/10.1038/onc.2009.127</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/onc.2009.174">
<title>Accelerated mammary maturation and differentiation, and delayed MMTVneu-induced tumorigenesis of K303R mutant ER&#945; transgenic mice</title>
<link>http://dx.doi.org/10.1038/onc.2009.174</link>
<content:encoded><![CDATA[
            
<p>
<b>Accelerated mammary maturation and differentiation, and delayed MMTVneu-induced tumorigenesis of K303R mutant ER&#945; transgenic mice</b>
</p>
<p>Oncogene advance online publication, June 29, 2009. <a href="http://dx.doi.org/10.1038/onc.2009.174">doi:10.1038/onc.2009.174</a>
</p>
<p>Authors: M H Herynk, M T Lewis, T A Hopp, D Medina, A Corona-Rodriguez, Y Cui, A R Beyer
                    &amp; S A W Fuqua</p>
]]></content:encoded>
<dc:title>Accelerated mammary maturation and differentiation, and delayed MMTVneu-induced tumorigenesis of K303R mutant ER&#945; transgenic mice</dc:title>
<dc:creator>M H Herynk</dc:creator>
<dc:creator>M T Lewis</dc:creator>
<dc:creator>T A Hopp</dc:creator>
<dc:creator>D Medina</dc:creator>
<dc:creator>A Corona-Rodriguez</dc:creator>
<dc:creator>Y Cui</dc:creator>
<dc:creator>A R Beyer</dc:creator>
<dc:creator>S A W Fuqua</dc:creator>
<dc:identifier>doi:10.1038/onc.2009.174</dc:identifier>
<dc:source>Oncogene advance online publication, June 29, 2009</dc:source>
<dc:date>2009-06-29</dc:date>
<prism:publicationName>Oncogene</prism:publicationName>
<prism:publicationDate>June 29, 2009</prism:publicationDate>
<prism:doi>10.1038/onc.2009.174</prism:doi>
<prism:url>http://dx.doi.org/10.1038/onc.2009.174</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/onc.2009.109">
<title>The human protein kinase HIPK2 phosphorylates and downregulates the methyl-binding transcription factor ZBTB4</title>
<link>http://dx.doi.org/10.1038/onc.2009.109</link>
<content:encoded><![CDATA[
            
<p>
<b>The human protein kinase HIPK2 phosphorylates and downregulates the methyl-binding transcription factor ZBTB4</b>
</p>
<p>Oncogene advance online publication, May 18, 2009. <a href="http://dx.doi.org/10.1038/onc.2009.109">doi:10.1038/onc.2009.109</a>
</p>
<p>Authors: D Yamada, R P&#233;rez-Torrado, G Filion, M Caly, B Jammart, V Devignot, N Sasai, P Ravassard, J Mallet, X Sastre-Garau, M L Schmitz
                    &amp; P -A Defossez</p>
]]></content:encoded>
<dc:title>The human protein kinase HIPK2 phosphorylates and downregulates the methyl-binding transcription factor ZBTB4</dc:title>
<dc:creator>D Yamada</dc:creator>
<dc:creator>R P&#233;rez-Torrado</dc:creator>
<dc:creator>G Filion</dc:creator>
<dc:creator>M Caly</dc:creator>
<dc:creator>B Jammart</dc:creator>
<dc:creator>V Devignot</dc:creator>
<dc:creator>N Sasai</dc:creator>
<dc:creator>P Ravassard</dc:creator>
<dc:creator>J Mallet</dc:creator>
<dc:creator>X Sastre-Garau</dc:creator>
<dc:creator>M L Schmitz</dc:creator>
<dc:creator>P -A Defossez</dc:creator>
<dc:identifier>doi:10.1038/onc.2009.109</dc:identifier>
<dc:source>Oncogene advance online publication, May 18, 2009</dc:source>
<dc:date>2009-05-18</dc:date>
<prism:publicationName>Oncogene</prism:publicationName>
<prism:publicationDate>May 18, 2009</prism:publicationDate>
<prism:doi>10.1038/onc.2009.109</prism:doi>
<prism:url>http://dx.doi.org/10.1038/onc.2009.109</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/onc.2009.138">
<title>p53 and little brother p53&#47;47: linking IRES activities with protein functions</title>
<link>http://dx.doi.org/10.1038/onc.2009.138</link>
<content:encoded><![CDATA[
            
<p>
<b>p53 and little brother p53&#47;47: linking IRES activities with protein functions</b>
</p>
<p>Oncogene advance online publication, June 1, 2009. <a href="http://dx.doi.org/10.1038/onc.2009.138">doi:10.1038/onc.2009.138</a>
</p>
<p>Authors: R Grover, M M Candeias, R F&#229;hraeus
                    &amp; S Das</p>
]]></content:encoded>
<dc:title>p53 and little brother p53&#47;47: linking IRES activities with protein functions</dc:title>
<dc:creator>R Grover</dc:creator>
<dc:creator>M M Candeias</dc:creator>
<dc:creator>R F&#229;hraeus</dc:creator>
<dc:creator>S Das</dc:creator>
<dc:identifier>doi:10.1038/onc.2009.138</dc:identifier>
<dc:source>Oncogene advance online publication, June 1, 2009</dc:source>
<dc:date>2009-06-01</dc:date>
<prism:publicationName>Oncogene</prism:publicationName>
<prism:publicationDate>June 1, 2009</prism:publicationDate>
<prism:doi>10.1038/onc.2009.138</prism:doi>
<prism:url>http://dx.doi.org/10.1038/onc.2009.138</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/onc.2009.149">
<title>Methylation profiles of 22 candidate genes in breast cancer using high-throughput MALDI-TOF mass array</title>
<link>http://dx.doi.org/10.1038/onc.2009.149</link>
<content:encoded><![CDATA[
            
<p>
<b>Methylation profiles of 22 candidate genes in breast cancer using high-throughput MALDI-TOF mass array</b>
</p>
<p>Oncogene advance online publication, June 8, 2009. <a href="http://dx.doi.org/10.1038/onc.2009.149">doi:10.1038/onc.2009.149</a>
</p>
<p>Authors: R Radpour, C Kohler, M M Haghighi, A X C Fan, W Holzgreve
                    &amp; X Y Zhong</p>
]]></content:encoded>
<dc:title>Methylation profiles of 22 candidate genes in breast cancer using high-throughput MALDI-TOF mass array</dc:title>
<dc:creator>R Radpour</dc:creator>
<dc:creator>C Kohler</dc:creator>
<dc:creator>M M Haghighi</dc:creator>
<dc:creator>A X C Fan</dc:creator>
<dc:creator>W Holzgreve</dc:creator>
<dc:creator>X Y Zhong</dc:creator>
<dc:identifier>doi:10.1038/onc.2009.149</dc:identifier>
<dc:source>Oncogene advance online publication, June 8, 2009</dc:source>
<dc:date>2009-06-08</dc:date>
<prism:publicationName>Oncogene</prism:publicationName>
<prism:publicationDate>June 8, 2009</prism:publicationDate>
<prism:doi>10.1038/onc.2009.149</prism:doi>
<prism:url>http://dx.doi.org/10.1038/onc.2009.149</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/onc.2009.178">
<title>Nucleophosmin protein expression level, but not threonine 198 phosphorylation, is essential in growth and proliferation</title>
<link>http://dx.doi.org/10.1038/onc.2009.178</link>
<content:encoded><![CDATA[
            
<p>
<b>Nucleophosmin protein expression level, but not threonine 198 phosphorylation, is essential in growth and proliferation</b>
</p>
<p>Oncogene advance online publication, June 29, 2009. <a href="http://dx.doi.org/10.1038/onc.2009.178">doi:10.1038/onc.2009.178</a>
</p>
<p>Authors: S N Brady, L B Maggi, C L Winkeler, E A Toso, A S Gwinn, C L Pelletier
                    &amp; J D Weber</p>
]]></content:encoded>
<dc:title>Nucleophosmin protein expression level, but not threonine 198 phosphorylation, is essential in growth and proliferation</dc:title>
<dc:creator>S N Brady</dc:creator>
<dc:creator>L B Maggi</dc:creator>
<dc:creator>C L Winkeler</dc:creator>
<dc:creator>E A Toso</dc:creator>
<dc:creator>A S Gwinn</dc:creator>
<dc:creator>C L Pelletier</dc:creator>
<dc:creator>J D Weber</dc:creator>
<dc:identifier>doi:10.1038/onc.2009.178</dc:identifier>
<dc:source>Oncogene advance online publication, June 29, 2009</dc:source>
<dc:date>2009-06-29</dc:date>
<prism:publicationName>Oncogene</prism:publicationName>
<prism:publicationDate>June 29, 2009</prism:publicationDate>
<prism:doi>10.1038/onc.2009.178</prism:doi>
<prism:url>http://dx.doi.org/10.1038/onc.2009.178</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/onc.2009.142">
<title>Cyclophilins contribute to Stat3 signaling and survival of multiple myeloma cells</title>
<link>http://dx.doi.org/10.1038/onc.2009.142</link>
<content:encoded><![CDATA[
            
<p>
<b>Cyclophilins contribute to Stat3 signaling and survival of multiple myeloma cells</b>
</p>
<p>Oncogene advance online publication, June 8, 2009. <a href="http://dx.doi.org/10.1038/onc.2009.142">doi:10.1038/onc.2009.142</a>
</p>
<p>Authors: K Bauer, A K Kretzschmar, H Cvijic, C Blumert, D L&#246;ffler, K Brocke-Heidrich, C Schiene-Fischer, G Fischer, A Sinz, C V Clevenger
                    &amp; F Horn</p>
]]></content:encoded>
<dc:title>Cyclophilins contribute to Stat3 signaling and survival of multiple myeloma cells</dc:title>
<dc:creator>K Bauer</dc:creator>
<dc:creator>A K Kretzschmar</dc:creator>
<dc:creator>H Cvijic</dc:creator>
<dc:creator>C Blumert</dc:creator>
<dc:creator>D L&#246;ffler</dc:creator>
<dc:creator>K Brocke-Heidrich</dc:creator>
<dc:creator>C Schiene-Fischer</dc:creator>
<dc:creator>G Fischer</dc:creator>
<dc:creator>A Sinz</dc:creator>
<dc:creator>C V Clevenger</dc:creator>
<dc:creator>F Horn</dc:creator>
<dc:identifier>doi:10.1038/onc.2009.142</dc:identifier>
<dc:source>Oncogene advance online publication, June 8, 2009</dc:source>
<dc:date>2009-06-08</dc:date>
<prism:publicationName>Oncogene</prism:publicationName>
<prism:publicationDate>June 8, 2009</prism:publicationDate>
<prism:doi>10.1038/onc.2009.142</prism:doi>
<prism:url>http://dx.doi.org/10.1038/onc.2009.142</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/onc.2009.153">
<title>A combinatorial mechanism for determining the specificity of E2F activation and repression</title>
<link>http://dx.doi.org/10.1038/onc.2009.153</link>
<content:encoded><![CDATA[
            
<p>
<b>A combinatorial mechanism for determining the specificity of E2F activation and repression</b>
</p>
<p>Oncogene advance online publication, June 22, 2009. <a href="http://dx.doi.org/10.1038/onc.2009.153">doi:10.1038/onc.2009.153</a>
</p>
<p>Authors: J A Freedman, J T Chang, L Jakoi
                    &amp; J R Nevins</p>
]]></content:encoded>
<dc:title>A combinatorial mechanism for determining the specificity of E2F activation and repression</dc:title>
<dc:creator>J A Freedman</dc:creator>
<dc:creator>J T Chang</dc:creator>
<dc:creator>L Jakoi</dc:creator>
<dc:creator>J R Nevins</dc:creator>
<dc:identifier>doi:10.1038/onc.2009.153</dc:identifier>
<dc:source>Oncogene advance online publication, June 22, 2009</dc:source>
<dc:date>2009-06-22</dc:date>
<prism:publicationName>Oncogene</prism:publicationName>
<prism:publicationDate>June 22, 2009</prism:publicationDate>
<prism:doi>10.1038/onc.2009.153</prism:doi>
<prism:url>http://dx.doi.org/10.1038/onc.2009.153</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/onc.2009.182">
<title>Post-translational modification and stability of low molecular weight cyclin E</title>
<link>http://dx.doi.org/10.1038/onc.2009.182</link>
<content:encoded><![CDATA[
            
<p>
<b>Post-translational modification and stability of low molecular weight cyclin E</b>
</p>
<p>Oncogene advance online publication, June 29, 2009. <a href="http://dx.doi.org/10.1038/onc.2009.182">doi:10.1038/onc.2009.182</a>
</p>
<p>Authors: B B Mull, J Cox, T Bui
                    &amp; K Keyomarsi</p>
]]></content:encoded>
<dc:title>Post-translational modification and stability of low molecular weight cyclin E</dc:title>
<dc:creator>B B Mull</dc:creator>
<dc:creator>J Cox</dc:creator>
<dc:creator>T Bui</dc:creator>
<dc:creator>K Keyomarsi</dc:creator>
<dc:identifier>doi:10.1038/onc.2009.182</dc:identifier>
<dc:source>Oncogene advance online publication, June 29, 2009</dc:source>
<dc:date>2009-06-29</dc:date>
<prism:publicationName>Oncogene</prism:publicationName>
<prism:publicationDate>June 29, 2009</prism:publicationDate>
<prism:doi>10.1038/onc.2009.182</prism:doi>
<prism:url>http://dx.doi.org/10.1038/onc.2009.182</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/onc.2009.146">
<title>The Ste20-like kinase SLK is required for ErbB2-driven breast cancer cell motility</title>
<link>http://dx.doi.org/10.1038/onc.2009.146</link>
<content:encoded><![CDATA[
            
<p>
<b>The Ste20-like kinase SLK is required for ErbB2-driven breast cancer cell motility</b>
</p>
<p>Oncogene advance online publication, June 15, 2009. <a href="http://dx.doi.org/10.1038/onc.2009.146">doi:10.1038/onc.2009.146</a>
</p>
<p>Authors: K Roovers, S Wagner, C J Storbeck, P O'Reilly, V Lo, J J Northey, J Chmielecki, W J Muller, P M Siegel
                    &amp; L A Sabourin</p>
]]></content:encoded>
<dc:title>The Ste20-like kinase SLK is required for ErbB2-driven breast cancer cell motility</dc:title>
<dc:creator>K Roovers</dc:creator>
<dc:creator>S Wagner</dc:creator>
<dc:creator>C J Storbeck</dc:creator>
<dc:creator>P O'Reilly</dc:creator>
<dc:creator>V Lo</dc:creator>
<dc:creator>J J Northey</dc:creator>
<dc:creator>J Chmielecki</dc:creator>
<dc:creator>W J Muller</dc:creator>
<dc:creator>P M Siegel</dc:creator>
<dc:creator>L A Sabourin</dc:creator>
<dc:identifier>doi:10.1038/onc.2009.146</dc:identifier>
<dc:source>Oncogene advance online publication, June 15, 2009</dc:source>
<dc:date>2009-06-15</dc:date>
<prism:publicationName>Oncogene</prism:publicationName>
<prism:publicationDate>June 15, 2009</prism:publicationDate>
<prism:doi>10.1038/onc.2009.146</prism:doi>
<prism:url>http://dx.doi.org/10.1038/onc.2009.146</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/onc.2009.120">
<title>Inhibition of the Wnt&#47;&#946;-catenin pathway by the WWOX tumor suppressor protein</title>
<link>http://dx.doi.org/10.1038/onc.2009.120</link>
<content:encoded><![CDATA[
            
<p>
<b>Inhibition of the Wnt&#47;&#946;-catenin pathway by the WWOX tumor suppressor protein</b>
</p>
<p>Oncogene advance online publication, May 25, 2009. <a href="http://dx.doi.org/10.1038/onc.2009.120">doi:10.1038/onc.2009.120</a>
</p>
<p>Authors: N Bouteille, K Driouch, P El Hage, S Sin, E Formstecher, J Camonis, R Lidereau
                    &amp; F Lallemand</p>
]]></content:encoded>
<dc:title>Inhibition of the Wnt&#47;&#946;-catenin pathway by the WWOX tumor suppressor protein</dc:title>
<dc:creator>N Bouteille</dc:creator>
<dc:creator>K Driouch</dc:creator>
<dc:creator>P El Hage</dc:creator>
<dc:creator>S Sin</dc:creator>
<dc:creator>E Formstecher</dc:creator>
<dc:creator>J Camonis</dc:creator>
<dc:creator>R Lidereau</dc:creator>
<dc:creator>F Lallemand</dc:creator>
<dc:identifier>doi:10.1038/onc.2009.120</dc:identifier>
<dc:source>Oncogene advance online publication, May 25, 2009</dc:source>
<dc:date>2009-05-25</dc:date>
<prism:publicationName>Oncogene</prism:publicationName>
<prism:publicationDate>May 25, 2009</prism:publicationDate>
<prism:doi>10.1038/onc.2009.120</prism:doi>
<prism:url>http://dx.doi.org/10.1038/onc.2009.120</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/onc.2009.160">
<title>Malonyl-CoA decarboxylase inhibition is selectively cytotoxic to human breast cancer cells</title>
<link>http://dx.doi.org/10.1038/onc.2009.160</link>
<content:encoded><![CDATA[
            
<p>
<b>Malonyl-CoA decarboxylase inhibition is selectively cytotoxic to human breast cancer cells</b>
</p>
<p>Oncogene advance online publication, June 22, 2009. <a href="http://dx.doi.org/10.1038/onc.2009.160">doi:10.1038/onc.2009.160</a>
</p>
<p>Authors: W Zhou, Y Tu, P J Simpson
                    &amp; F P Kuhajda</p>
]]></content:encoded>
<dc:title>Malonyl-CoA decarboxylase inhibition is selectively cytotoxic to human breast cancer cells</dc:title>
<dc:creator>W Zhou</dc:creator>
<dc:creator>Y Tu</dc:creator>
<dc:creator>P J Simpson</dc:creator>
<dc:creator>F P Kuhajda</dc:creator>
<dc:identifier>doi:10.1038/onc.2009.160</dc:identifier>
<dc:source>Oncogene advance online publication, June 22, 2009</dc:source>
<dc:date>2009-06-22</dc:date>
<prism:publicationName>Oncogene</prism:publicationName>
<prism:publicationDate>June 22, 2009</prism:publicationDate>
<prism:doi>10.1038/onc.2009.160</prism:doi>
<prism:url>http://dx.doi.org/10.1038/onc.2009.160</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/onc.2009.175">
<title>Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a&#47;Ror2 signaling</title>
<link>http://dx.doi.org/10.1038/onc.2009.175</link>
<content:encoded><![CDATA[
            
<p>
<b>Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a&#47;Ror2 signaling</b>
</p>
<p>Oncogene advance online publication, June 29, 2009. <a href="http://dx.doi.org/10.1038/onc.2009.175">doi:10.1038/onc.2009.175</a>
</p>
<p>Authors: M Enomoto, S Hayakawa, S Itsukushima, D Y Ren, M Matsuo, K Tamada, C Oneyama, M Okada, T Takumi, M Nishita
                    &amp; Y Minami</p>
]]></content:encoded>
<dc:title>Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a&#47;Ror2 signaling</dc:title>
<dc:creator>M Enomoto</dc:creator>
<dc:creator>S Hayakawa</dc:creator>
<dc:creator>S Itsukushima</dc:creator>
<dc:creator>D Y Ren</dc:creator>
<dc:creator>M Matsuo</dc:creator>
<dc:creator>K Tamada</dc:creator>
<dc:creator>C Oneyama</dc:creator>
<dc:creator>M Okada</dc:creator>
<dc:creator>T Takumi</dc:creator>
<dc:creator>M Nishita</dc:creator>
<dc:creator>Y Minami</dc:creator>
<dc:identifier>doi:10.1038/onc.2009.175</dc:identifier>
<dc:source>Oncogene advance online publication, June 29, 2009</dc:source>
<dc:date>2009-06-29</dc:date>
<prism:publicationName>Oncogene</prism:publicationName>
<prism:publicationDate>June 29, 2009</prism:publicationDate>
<prism:doi>10.1038/onc.2009.175</prism:doi>
<prism:url>http://dx.doi.org/10.1038/onc.2009.175</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/onc.2009.131">
<title>The canonical NF-&#954;B pathway is required for formation of luminal mammary neoplasias and is activated in the mammary progenitor population</title>
<link>http://dx.doi.org/10.1038/onc.2009.131</link>
<content:encoded><![CDATA[
            
<p>
<b>The canonical NF-&#954;B pathway is required for formation of luminal mammary neoplasias and is activated in the mammary progenitor population</b>
</p>
<p>Oncogene advance online publication, June 1, 2009. <a href="http://dx.doi.org/10.1038/onc.2009.131">doi:10.1038/onc.2009.131</a>
</p>
<p>Authors: M A C Pratt, E Tibbo, S J Robertson, D Jansson, K Hurst, C Perez-Iratxeta, R Lau
                    &amp; M Y Niu</p>
]]></content:encoded>
<dc:title>The canonical NF-&#954;B pathway is required for formation of luminal mammary neoplasias and is activated in the mammary progenitor population</dc:title>
<dc:creator>M A C Pratt</dc:creator>
<dc:creator>E Tibbo</dc:creator>
<dc:creator>S J Robertson</dc:creator>
<dc:creator>D Jansson</dc:creator>
<dc:creator>K Hurst</dc:creator>
<dc:creator>C Perez-Iratxeta</dc:creator>
<dc:creator>R Lau</dc:creator>
<dc:creator>M Y Niu</dc:creator>
<dc:identifier>doi:10.1038/onc.2009.131</dc:identifier>
<dc:source>Oncogene advance online publication, June 1, 2009</dc:source>
<dc:date>2009-06-01</dc:date>
<prism:publicationName>Oncogene</prism:publicationName>
<prism:publicationDate>June 1, 2009</prism:publicationDate>
<prism:doi>10.1038/onc.2009.131</prism:doi>
<prism:url>http://dx.doi.org/10.1038/onc.2009.131</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/onc.2009.124">
<title>Pim-1 plays a pivotal role in hypoxia-induced chemoresistance</title>
<link>http://dx.doi.org/10.1038/onc.2009.124</link>
<content:encoded><![CDATA[
            
<p>
<b>Pim-1 plays a pivotal role in hypoxia-induced chemoresistance</b>
</p>
<p>Oncogene advance online publication, June 1, 2009. <a href="http://dx.doi.org/10.1038/onc.2009.124">doi:10.1038/onc.2009.124</a>
</p>
<p>Authors: J Chen, M Kobayashi, S Darmanin, Y Qiao, C Gully, R Zhao, S C Yeung
                    &amp; M H Lee</p>
]]></content:encoded>
<dc:title>Pim-1 plays a pivotal role in hypoxia-induced chemoresistance</dc:title>
<dc:creator>J Chen</dc:creator>
<dc:creator>M Kobayashi</dc:creator>
<dc:creator>S Darmanin</dc:creator>
<dc:creator>Y Qiao</dc:creator>
<dc:creator>C Gully</dc:creator>
<dc:creator>R Zhao</dc:creator>
<dc:creator>S C Yeung</dc:creator>
<dc:creator>M H Lee</dc:creator>
<dc:identifier>doi:10.1038/onc.2009.124</dc:identifier>
<dc:source>Oncogene advance online publication, June 1, 2009</dc:source>
<dc:date>2009-06-01</dc:date>
<prism:publicationName>Oncogene</prism:publicationName>
<prism:publicationDate>June 1, 2009</prism:publicationDate>
<prism:doi>10.1038/onc.2009.124</prism:doi>
<prism:url>http://dx.doi.org/10.1038/onc.2009.124</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/onc.2009.164">
<title>Functional RET G691S polymorphism in cutaneous malignant melanoma</title>
<link>http://dx.doi.org/10.1038/onc.2009.164</link>
<content:encoded><![CDATA[
            
<p>
<b>Functional RET G691S polymorphism in cutaneous malignant melanoma</b>
</p>
<p>Oncogene advance online publication, June 29, 2009. <a href="http://dx.doi.org/10.1038/onc.2009.164">doi:10.1038/onc.2009.164</a>
</p>
<p>Authors: N Narita, A Tanemura, R Murali, R A Scolyer, S Huang, T Arigami, S Yanagita, K K Chong, J F Thompson, D L Morton
                    &amp; D S Hoon</p>
]]></content:encoded>
<dc:title>Functional RET G691S polymorphism in cutaneous malignant melanoma</dc:title>
<dc:creator>N Narita</dc:creator>
<dc:creator>A Tanemura</dc:creator>
<dc:creator>R Murali</dc:creator>
<dc:creator>R A Scolyer</dc:creator>
<dc:creator>S Huang</dc:creator>
<dc:creator>T Arigami</dc:creator>
<dc:creator>S Yanagita</dc:creator>
<dc:creator>K K Chong</dc:creator>
<dc:creator>J F Thompson</dc:creator>
<dc:creator>D L Morton</dc:creator>
<dc:creator>D S Hoon</dc:creator>
<dc:identifier>doi:10.1038/onc.2009.164</dc:identifier>
<dc:source>Oncogene advance online publication, June 29, 2009</dc:source>
<dc:date>2009-06-29</dc:date>
<prism:publicationName>Oncogene</prism:publicationName>
<prism:publicationDate>June 29, 2009</prism:publicationDate>
<prism:doi>10.1038/onc.2009.164</prism:doi>
<prism:url>http://dx.doi.org/10.1038/onc.2009.164</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/onc.2009.135">
<title>An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors</title>
<link>http://dx.doi.org/10.1038/onc.2009.135</link>
<content:encoded><![CDATA[
            
<p>
<b>An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors</b>
</p>
<p>Oncogene advance online publication, June 15, 2009. <a href="http://dx.doi.org/10.1038/onc.2009.135">doi:10.1038/onc.2009.135</a>
</p>
<p>Authors: D Chitale, Y Gong, B S Taylor, S Broderick, C Brennan, R Somwar, B Golas, L Wang, N Motoi, J Szoke, J M Reinersman, J Major, C Sander, V E Seshan, M F Zakowski, V Rusch, W Pao, W Gerald
                    &amp; M Ladanyi</p>
]]></content:encoded>
<dc:title>An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors</dc:title>
<dc:creator>D Chitale</dc:creator>
<dc:creator>Y Gong</dc:creator>
<dc:creator>B S Taylor</dc:creator>
<dc:creator>S Broderick</dc:creator>
<dc:creator>C Brennan</dc:creator>
<dc:creator>R Somwar</dc:creator>
<dc:creator>B Golas</dc:creator>
<dc:creator>L Wang</dc:creator>
<dc:creator>N Motoi</dc:creator>
<dc:creator>J Szoke</dc:creator>
<dc:creator>J M Reinersman</dc:creator>
<dc:creator>J Major</dc:creator>
<dc:creator>C Sander</dc:creator>
<dc:creator>V E Seshan</dc:creator>
<dc:creator>M F Zakowski</dc:creator>
<dc:creator>V Rusch</dc:creator>
<dc:creator>W Pao</dc:creator>
<dc:creator>W Gerald</dc:creator>
<dc:creator>M Ladanyi</dc:creator>
<dc:identifier>doi:10.1038/onc.2009.135</dc:identifier>
<dc:source>Oncogene advance online publication, June 15, 2009</dc:source>
<dc:date>2009-06-15</dc:date>
<prism:publicationName>Oncogene</prism:publicationName>
<prism:publicationDate>June 15, 2009</prism:publicationDate>
<prism:doi>10.1038/onc.2009.135</prism:doi>
<prism:url>http://dx.doi.org/10.1038/onc.2009.135</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/onc.2009.128">
<title>Expression of FLJ10540 is correlated with aggressiveness of oral cavity squamous cell carcinoma by stimulating cell migration and invasion through increased FOXM1 and MMP-2 activity</title>
<link>http://dx.doi.org/10.1038/onc.2009.128</link>
<content:encoded><![CDATA[
            
<p>
<b>Expression of FLJ10540 is correlated with aggressiveness of oral cavity squamous cell carcinoma by stimulating cell migration and invasion through increased FOXM1 and MMP-2 activity</b>
</p>
<p>Oncogene advance online publication, June 15, 2009. <a href="http://dx.doi.org/10.1038/onc.2009.128">doi:10.1038/onc.2009.128</a>
</p>
<p>Authors: C-H Chen, C-Y Chien, C-C Huang, C-F Hwang, H-C Chuang, F-M Fang, H-Y Huang, C-M Chen, H-L Liu
                    &amp; C-YF Huang</p>
]]></content:encoded>
<dc:title>Expression of FLJ10540 is correlated with aggressiveness of oral cavity squamous cell carcinoma by stimulating cell migration and invasion through increased FOXM1 and MMP-2 activity</dc:title>
<dc:creator>C-H Chen</dc:creator>
<dc:creator>C-Y Chien</dc:creator>
<dc:creator>C-C Huang</dc:creator>
<dc:creator>C-F Hwang</dc:creator>
<dc:creator>H-C Chuang</dc:creator>
<dc:creator>F-M Fang</dc:creator>
<dc:creator>H-Y Huang</dc:creator>
<dc:creator>C-M Chen</dc:creator>
<dc:creator>H-L Liu</dc:creator>
<dc:creator>C-YF Huang</dc:creator>
<dc:identifier>doi:10.1038/onc.2009.128</dc:identifier>
<dc:source>Oncogene advance online publication, June 15, 2009</dc:source>
<dc:date>2009-06-15</dc:date>
<prism:publicationName>Oncogene</prism:publicationName>
<prism:publicationDate>June 15, 2009</prism:publicationDate>
<prism:doi>10.1038/onc.2009.128</prism:doi>
<prism:url>http://dx.doi.org/10.1038/onc.2009.128</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/onc.2009.168">
<title>Cyclic GMP-dependent protein kinase II inhibits cell proliferation, Sox9 expression and Akt phosphorylation in human glioma cell lines</title>
<link>http://dx.doi.org/10.1038/onc.2009.168</link>
<content:encoded><![CDATA[
            
<p>
<b>Cyclic GMP-dependent protein kinase II inhibits cell proliferation, Sox9 expression and Akt phosphorylation in human glioma cell lines</b>
</p>
<p>Oncogene advance online publication, June 22, 2009. <a href="http://dx.doi.org/10.1038/onc.2009.168">doi:10.1038/onc.2009.168</a>
</p>
<p>Authors: F J Swartling, M Ferletta, M Kastemar, W A Weiss
                    &amp; B Westermark</p>
]]></content:encoded>
<dc:title>Cyclic GMP-dependent protein kinase II inhibits cell proliferation, Sox9 expression and Akt phosphorylation in human glioma cell lines</dc:title>
<dc:creator>F J Swartling</dc:creator>
<dc:creator>M Ferletta</dc:creator>
<dc:creator>M Kastemar</dc:creator>
<dc:creator>W A Weiss</dc:creator>
<dc:creator>B Westermark</dc:creator>
<dc:identifier>doi:10.1038/onc.2009.168</dc:identifier>
<dc:source>Oncogene advance online publication, June 22, 2009</dc:source>
<dc:date>2009-06-22</dc:date>
<prism:publicationName>Oncogene</prism:publicationName>
<prism:publicationDate>June 22, 2009</prism:publicationDate>
<prism:doi>10.1038/onc.2009.168</prism:doi>
<prism:url>http://dx.doi.org/10.1038/onc.2009.168</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/onc.2009.139">
<title>Anchorage-independent cell growth signature identifies tumors with metastatic potential</title>
<link>http://dx.doi.org/10.1038/onc.2009.139</link>
<content:encoded><![CDATA[
            
<p>
<b>Anchorage-independent cell growth signature identifies tumors with metastatic potential</b>
</p>
<p>Oncogene advance online publication, June 1, 2009. <a href="http://dx.doi.org/10.1038/onc.2009.139">doi:10.1038/onc.2009.139</a>
</p>
<p>Authors: S Mori, J T Chang, E R Andrechek, N Matsumura, T Baba, G Yao, J W Kim, M Gatza, S Murphy
                    &amp; J R Nevins</p>
]]></content:encoded>
<dc:title>Anchorage-independent cell growth signature identifies tumors with metastatic potential</dc:title>
<dc:creator>S Mori</dc:creator>
<dc:creator>J T Chang</dc:creator>
<dc:creator>E R Andrechek</dc:creator>
<dc:creator>N Matsumura</dc:creator>
<dc:creator>T Baba</dc:creator>
<dc:creator>G Yao</dc:creator>
<dc:creator>J W Kim</dc:creator>
<dc:creator>M Gatza</dc:creator>
<dc:creator>S Murphy</dc:creator>
<dc:creator>J R Nevins</dc:creator>
<dc:identifier>doi:10.1038/onc.2009.139</dc:identifier>
<dc:source>Oncogene advance online publication, June 1, 2009</dc:source>
<dc:date>2009-06-01</dc:date>
<prism:publicationName>Oncogene</prism:publicationName>
<prism:publicationDate>June 1, 2009</prism:publicationDate>
<prism:doi>10.1038/onc.2009.139</prism:doi>
<prism:url>http://dx.doi.org/10.1038/onc.2009.139</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/onc.2009.183">
<title>Involvement of mitochondria and recruitment of Fas&#47;CD95 signaling in lipid rafts in resveratrol-mediated antimyeloma and antileukemia actions</title>
<link>http://dx.doi.org/10.1038/onc.2009.183</link>
<content:encoded><![CDATA[
            
<p>
<b>Involvement of mitochondria and recruitment of Fas&#47;CD95 signaling in lipid rafts in resveratrol-mediated antimyeloma and antileukemia actions</b>
</p>
<p>Oncogene advance online publication, June 29, 2009. <a href="http://dx.doi.org/10.1038/onc.2009.183">doi:10.1038/onc.2009.183</a>
</p>
<p>Authors: M Reis-Sobreiro, C Gajate
                    &amp; F Mollinedo</p>
]]></content:encoded>
<dc:title>Involvement of mitochondria and recruitment of Fas&#47;CD95 signaling in lipid rafts in resveratrol-mediated antimyeloma and antileukemia actions</dc:title>
<dc:creator>M Reis-Sobreiro</dc:creator>
<dc:creator>C Gajate</dc:creator>
<dc:creator>F Mollinedo</dc:creator>
<dc:identifier>doi:10.1038/onc.2009.183</dc:identifier>
<dc:source>Oncogene advance online publication, June 29, 2009</dc:source>
<dc:date>2009-06-29</dc:date>
<prism:publicationName>Oncogene</prism:publicationName>
<prism:publicationDate>June 29, 2009</prism:publicationDate>
<prism:doi>10.1038/onc.2009.183</prism:doi>
<prism:url>http://dx.doi.org/10.1038/onc.2009.183</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/onc.2009.132">
<title>Cleaved high-molecular-weight kininogen and its domain 5 inhibit migration and invasion of human prostate cancer cells through the epidermal growth factor receptor pathway</title>
<link>http://dx.doi.org/10.1038/onc.2009.132</link>
<content:encoded><![CDATA[
            
<p>
<b>Cleaved high-molecular-weight kininogen and its domain 5 inhibit migration and invasion of human prostate cancer cells through the epidermal growth factor receptor pathway</b>
</p>
<p>Oncogene advance online publication, June 1, 2009. <a href="http://dx.doi.org/10.1038/onc.2009.132">doi:10.1038/onc.2009.132</a>
</p>
<p>Authors: Y Liu, R Pixley, M Fusaro, G Godoy, E Kim, M E Bromberg
                    &amp; R W Colman</p>
]]></content:encoded>
<dc:title>Cleaved high-molecular-weight kininogen and its domain 5 inhibit migration and invasion of human prostate cancer cells through the epidermal growth factor receptor pathway</dc:title>
<dc:creator>Y Liu</dc:creator>
<dc:creator>R Pixley</dc:creator>
<dc:creator>M Fusaro</dc:creator>
<dc:creator>G Godoy</dc:creator>
<dc:creator>E Kim</dc:creator>
<dc:creator>M E Bromberg</dc:creator>
<dc:creator>R W Colman</dc:creator>
<dc:identifier>doi:10.1038/onc.2009.132</dc:identifier>
<dc:source>Oncogene advance online publication, June 1, 2009</dc:source>
<dc:date>2009-06-01</dc:date>
<prism:publicationName>Oncogene</prism:publicationName>
<prism:publicationDate>June 1, 2009</prism:publicationDate>
<prism:doi>10.1038/onc.2009.132</prism:doi>
<prism:url>http://dx.doi.org/10.1038/onc.2009.132</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/onc.2009.147">
<title>SirT1-null mice develop tumors at normal rates but are poorly protected by resveratrol</title>
<link>http://dx.doi.org/10.1038/onc.2009.147</link>
<content:encoded><![CDATA[
            
<p>
<b>SirT1-null mice develop tumors at normal rates but are poorly protected by resveratrol</b>
</p>
<p>Oncogene advance online publication, June 8, 2009. <a href="http://dx.doi.org/10.1038/onc.2009.147">doi:10.1038/onc.2009.147</a>
</p>
<p>Authors: G Boily, X H He, B Pearce, K Jardine
                    &amp; M W McBurney</p>
]]></content:encoded>
<dc:title>SirT1-null mice develop tumors at normal rates but are poorly protected by resveratrol</dc:title>
<dc:creator>G Boily</dc:creator>
<dc:creator>X H He</dc:creator>
<dc:creator>B Pearce</dc:creator>
<dc:creator>K Jardine</dc:creator>
<dc:creator>M W McBurney</dc:creator>
<dc:identifier>doi:10.1038/onc.2009.147</dc:identifier>
<dc:source>Oncogene advance online publication, June 8, 2009</dc:source>
<dc:date>2009-06-08</dc:date>
<prism:publicationName>Oncogene</prism:publicationName>
<prism:publicationDate>June 8, 2009</prism:publicationDate>
<prism:doi>10.1038/onc.2009.147</prism:doi>
<prism:url>http://dx.doi.org/10.1038/onc.2009.147</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/onc.2009.150">
<title>Combined genomic and gene expression microarray profiling identifies ECOP as an upregulated gene in squamous cell carcinomas independent of DNA amplification</title>
<link>http://dx.doi.org/10.1038/onc.2009.150</link>
<content:encoded><![CDATA[
            
<p>
<b>Combined genomic and gene expression microarray profiling identifies ECOP as an upregulated gene in squamous cell carcinomas independent of DNA amplification</b>
</p>
<p>Oncogene advance online publication, June 15, 2009. <a href="http://dx.doi.org/10.1038/onc.2009.150">doi:10.1038/onc.2009.150</a>
</p>
<p>Authors: A Baras, Y Yu, M Filtz, B Kim
                    &amp; C A Moskaluk</p>
]]></content:encoded>
<dc:title>Combined genomic and gene expression microarray profiling identifies ECOP as an upregulated gene in squamous cell carcinomas independent of DNA amplification</dc:title>
<dc:creator>A Baras</dc:creator>
<dc:creator>Y Yu</dc:creator>
<dc:creator>M Filtz</dc:creator>
<dc:creator>B Kim</dc:creator>
<dc:creator>C A Moskaluk</dc:creator>
<dc:identifier>doi:10.1038/onc.2009.150</dc:identifier>
<dc:source>Oncogene advance online publication, June 15, 2009</dc:source>
<dc:date>2009-06-15</dc:date>
<prism:publicationName>Oncogene</prism:publicationName>
<prism:publicationDate>June 15, 2009</prism:publicationDate>
<prism:doi>10.1038/onc.2009.150</prism:doi>
<prism:url>http://dx.doi.org/10.1038/onc.2009.150</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/onc.2009.165">
<title>BMI1 cooperates with H-RAS to induce an aggressive breast cancer phenotype with brain metastases</title>
<link>http://dx.doi.org/10.1038/onc.2009.165</link>
<content:encoded><![CDATA[
            
<p>
<b>BMI1 cooperates with H-RAS to induce an aggressive breast cancer phenotype with brain metastases</b>
</p>
<p>Oncogene advance online publication, June 22, 2009. <a href="http://dx.doi.org/10.1038/onc.2009.165">doi:10.1038/onc.2009.165</a>
</p>
<p>Authors: M J Hoenerhoff, I Chu, D Barkan, Z-y Liu, S Datta, G P Dimri
                    &amp; J E Green</p>
]]></content:encoded>
<dc:title>BMI1 cooperates with H-RAS to induce an aggressive breast cancer phenotype with brain metastases</dc:title>
<dc:creator>M J Hoenerhoff</dc:creator>
<dc:creator>I Chu</dc:creator>
<dc:creator>D Barkan</dc:creator>
<dc:creator>Z-y Liu</dc:creator>
<dc:creator>S Datta</dc:creator>
<dc:creator>G P Dimri</dc:creator>
<dc:creator>J E Green</dc:creator>
<dc:identifier>doi:10.1038/onc.2009.165</dc:identifier>
<dc:source>Oncogene advance online publication, June 22, 2009</dc:source>
<dc:date>2009-06-22</dc:date>
<prism:publicationName>Oncogene</prism:publicationName>
<prism:publicationDate>June 22, 2009</prism:publicationDate>
<prism:doi>10.1038/onc.2009.165</prism:doi>
<prism:url>http://dx.doi.org/10.1038/onc.2009.165</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/onc.2009.136">
<title>Upregulation of survivin during immortalization of nontransformed human fibroblasts transduced with telomerase reverse transcriptase</title>
<link>http://dx.doi.org/10.1038/onc.2009.136</link>
<content:encoded><![CDATA[
            
<p>
<b>Upregulation of survivin during immortalization of nontransformed human fibroblasts transduced with telomerase reverse transcriptase</b>
</p>
<p>Oncogene advance online publication, June 1, 2009. <a href="http://dx.doi.org/10.1038/onc.2009.136">doi:10.1038/onc.2009.136</a>
</p>
<p>Authors: J Yuan, B M-P Yang, Z-H Zhong, I Shats, M Milyavsky, V Rotter, R B Lock, R R Reddel
                    &amp; K L MacKenzie</p>
]]></content:encoded>
<dc:title>Upregulation of survivin during immortalization of nontransformed human fibroblasts transduced with telomerase reverse transcriptase</dc:title>
<dc:creator>J Yuan</dc:creator>
<dc:creator>B M-P Yang</dc:creator>
<dc:creator>Z-H Zhong</dc:creator>
<dc:creator>I Shats</dc:creator>
<dc:creator>M Milyavsky</dc:creator>
<dc:creator>V Rotter</dc:creator>
<dc:creator>R B Lock</dc:creator>
<dc:creator>R R Reddel</dc:creator>
<dc:creator>K L MacKenzie</dc:creator>
<dc:identifier>doi:10.1038/onc.2009.136</dc:identifier>
<dc:source>Oncogene advance online publication, June 1, 2009</dc:source>
<dc:date>2009-06-01</dc:date>
<prism:publicationName>Oncogene</prism:publicationName>
<prism:publicationDate>June 1, 2009</prism:publicationDate>
<prism:doi>10.1038/onc.2009.136</prism:doi>
<prism:url>http://dx.doi.org/10.1038/onc.2009.136</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/onc.2009.121">
<title>The SWI&#47;SNF chromatin remodeling subunit BRG1 is a critical regulator of p53 necessary for proliferation of malignant cells</title>
<link>http://dx.doi.org/10.1038/onc.2009.121</link>
<content:encoded><![CDATA[
            
<p>
<b>The SWI&#47;SNF chromatin remodeling subunit BRG1 is a critical regulator of p53 necessary for proliferation of malignant cells</b>
</p>
<p>Oncogene advance online publication, May 18, 2009. <a href="http://dx.doi.org/10.1038/onc.2009.121">doi:10.1038/onc.2009.121</a>
</p>
<p>Authors: S R Naidu, I M Love, A N Imbalzano, S R Grossman
                    &amp; E J Androphy</p>
]]></content:encoded>
<dc:title>The SWI&#47;SNF chromatin remodeling subunit BRG1 is a critical regulator of p53 necessary for proliferation of malignant cells</dc:title>
<dc:creator>S R Naidu</dc:creator>
<dc:creator>I M Love</dc:creator>
<dc:creator>A N Imbalzano</dc:creator>
<dc:creator>S R Grossman</dc:creator>
<dc:creator>E J Androphy</dc:creator>
<dc:identifier>doi:10.1038/onc.2009.121</dc:identifier>
<dc:source>Oncogene advance online publication, May 18, 2009</dc:source>
<dc:date>2009-05-18</dc:date>
<prism:publicationName>Oncogene</prism:publicationName>
<prism:publicationDate>May 18, 2009</prism:publicationDate>
<prism:doi>10.1038/onc.2009.121</prism:doi>
<prism:url>http://dx.doi.org/10.1038/onc.2009.121</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/onc.2009.154">
<title>XEDAR as a putative colorectal tumor suppressor that mediates p53-regulated anoikis pathway</title>
<link>http://dx.doi.org/10.1038/onc.2009.154</link>
<content:encoded><![CDATA[
            
<p>
<b>XEDAR as a putative colorectal tumor suppressor that mediates p53-regulated anoikis pathway</b>
</p>
<p>Oncogene advance online publication, June 22, 2009. <a href="http://dx.doi.org/10.1038/onc.2009.154">doi:10.1038/onc.2009.154</a>
</p>
<p>Authors: C Tanikawa, Y Furukawa, N Yoshida, H Arakawa, Y Nakamura
                    &amp; K Matsuda</p>
]]></content:encoded>
<dc:title>XEDAR as a putative colorectal tumor suppressor that mediates p53-regulated anoikis pathway</dc:title>
<dc:creator>C Tanikawa</dc:creator>
<dc:creator>Y Furukawa</dc:creator>
<dc:creator>N Yoshida</dc:creator>
<dc:creator>H Arakawa</dc:creator>
<dc:creator>Y Nakamura</dc:creator>
<dc:creator>K Matsuda</dc:creator>
<dc:identifier>doi:10.1038/onc.2009.154</dc:identifier>
<dc:source>Oncogene advance online publication, June 22, 2009</dc:source>
<dc:date>2009-06-22</dc:date>
<prism:publicationName>Oncogene</prism:publicationName>
<prism:publicationDate>June 22, 2009</prism:publicationDate>
<prism:doi>10.1038/onc.2009.154</prism:doi>
<prism:url>http://dx.doi.org/10.1038/onc.2009.154</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/onc.2009.118">
<title>A novel role for MAP1 LC3 in nonautophagic cytoplasmic vacuolation death of cancer cells</title>
<link>http://dx.doi.org/10.1038/onc.2009.118</link>
<content:encoded><![CDATA[
            
<p>
<b>A novel role for MAP1 LC3 in nonautophagic cytoplasmic vacuolation death of cancer cells</b>
</p>
<p>Oncogene advance online publication, May 18, 2009. <a href="http://dx.doi.org/10.1038/onc.2009.118">doi:10.1038/onc.2009.118</a>
</p>
<p>Authors: R Kar, P K Singha, M A Venkatachalam
                    &amp; P Saikumar</p>
]]></content:encoded>
<dc:title>A novel role for MAP1 LC3 in nonautophagic cytoplasmic vacuolation death of cancer cells</dc:title>
<dc:creator>R Kar</dc:creator>
<dc:creator>P K Singha</dc:creator>
<dc:creator>M A Venkatachalam</dc:creator>
<dc:creator>P Saikumar</dc:creator>
<dc:identifier>doi:10.1038/onc.2009.118</dc:identifier>
<dc:source>Oncogene advance online publication, May 18, 2009</dc:source>
<dc:date>2009-05-18</dc:date>
<prism:publicationName>Oncogene</prism:publicationName>
<prism:publicationDate>May 18, 2009</prism:publicationDate>
<prism:doi>10.1038/onc.2009.118</prism:doi>
<prism:url>http://dx.doi.org/10.1038/onc.2009.118</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/onc.2009.169">
<title>SOCS1 protects protein tyrosine phosphatases by thioredoxin upregulation and attenuates Jaks to suppress ROS-mediated apoptosis</title>
<link>http://dx.doi.org/10.1038/onc.2009.169</link>
<content:encoded><![CDATA[
            
<p>
<b>SOCS1 protects protein tyrosine phosphatases by thioredoxin upregulation and attenuates Jaks to suppress ROS-mediated apoptosis</b>
</p>
<p>Oncogene advance online publication, June 29, 2009. <a href="http://dx.doi.org/10.1038/onc.2009.169">doi:10.1038/onc.2009.169</a>
</p>
<p>Authors: J Oh, M-W Hur
                    &amp; C-E Lee</p>
]]></content:encoded>
<dc:title>SOCS1 protects protein tyrosine phosphatases by thioredoxin upregulation and attenuates Jaks to suppress ROS-mediated apoptosis</dc:title>
<dc:creator>J Oh</dc:creator>
<dc:creator>M-W Hur</dc:creator>
<dc:creator>C-E Lee</dc:creator>
<dc:identifier>doi:10.1038/onc.2009.169</dc:identifier>
<dc:source>Oncogene advance online publication, June 29, 2009</dc:source>
<dc:date>2009-06-29</dc:date>
<prism:publicationName>Oncogene</prism:publicationName>
<prism:publicationDate>June 29, 2009</prism:publicationDate>
<prism:doi>10.1038/onc.2009.169</prism:doi>
<prism:url>http://dx.doi.org/10.1038/onc.2009.169</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/onc.2009.125">
<title>Reactive oxygen species and lipoxygenases regulate the oncogenicity of NPM-ALK-positive anaplastic large cell lymphomas</title>
<link>http://dx.doi.org/10.1038/onc.2009.125</link>
<content:encoded><![CDATA[
            
<p>
<b>Reactive oxygen species and lipoxygenases regulate the oncogenicity of NPM-ALK-positive anaplastic large cell lymphomas</b>
</p>
<p>Oncogene advance online publication, June 8, 2009. <a href="http://dx.doi.org/10.1038/onc.2009.125">doi:10.1038/onc.2009.125</a>
</p>
<p>Authors: K Thornber, A Colomba, L Ceccato, G Delsol, B Payrastre
                    &amp; F Gaits-Iacovoni</p>
]]></content:encoded>
<dc:title>Reactive oxygen species and lipoxygenases regulate the oncogenicity of NPM-ALK-positive anaplastic large cell lymphomas</dc:title>
<dc:creator>K Thornber</dc:creator>
<dc:creator>A Colomba</dc:creator>
<dc:creator>L Ceccato</dc:creator>
<dc:creator>G Delsol</dc:creator>
<dc:creator>B Payrastre</dc:creator>
<dc:creator>F Gaits-Iacovoni</dc:creator>
<dc:identifier>doi:10.1038/onc.2009.125</dc:identifier>
<dc:source>Oncogene advance online publication, June 8, 2009</dc:source>
<dc:date>2009-06-08</dc:date>
<prism:publicationName>Oncogene</prism:publicationName>
<prism:publicationDate>June 8, 2009</prism:publicationDate>
<prism:doi>10.1038/onc.2009.125</prism:doi>
<prism:url>http://dx.doi.org/10.1038/onc.2009.125</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/onc.2009.158">
<title>Significance of RRM1 and ERCC1 expression in resectable pancreatic adenocarcinoma</title>
<link>http://dx.doi.org/10.1038/onc.2009.158</link>
<content:encoded><![CDATA[
            
<p>
<b>Significance of RRM1 and ERCC1 expression in resectable pancreatic adenocarcinoma</b>
</p>
<p>Oncogene advance online publication, June 22, 2009. <a href="http://dx.doi.org/10.1038/onc.2009.158">doi:10.1038/onc.2009.158</a>
</p>
<p>Authors: H Akita, Z Zheng, Y Takeda, C Kim, N Kittaka, S Kobayashi, S Marubashi, I Takemasa, H Nagano, K Dono, S Nakamori, M Monden, M Mori, Y Doki
                    &amp; G Bepler</p>
]]></content:encoded>
<dc:title>Significance of RRM1 and ERCC1 expression in resectable pancreatic adenocarcinoma</dc:title>
<dc:creator>H Akita</dc:creator>
<dc:creator>Z Zheng</dc:creator>
<dc:creator>Y Takeda</dc:creator>
<dc:creator>C Kim</dc:creator>
<dc:creator>N Kittaka</dc:creator>
<dc:creator>S Kobayashi</dc:creator>
<dc:creator>S Marubashi</dc:creator>
<dc:creator>I Takemasa</dc:creator>
<dc:creator>H Nagano</dc:creator>
<dc:creator>K Dono</dc:creator>
<dc:creator>S Nakamori</dc:creator>
<dc:creator>M Monden</dc:creator>
<dc:creator>M Mori</dc:creator>
<dc:creator>Y Doki</dc:creator>
<dc:creator>G Bepler</dc:creator>
<dc:identifier>doi:10.1038/onc.2009.158</dc:identifier>
<dc:source>Oncogene advance online publication, June 22, 2009</dc:source>
<dc:date>2009-06-22</dc:date>
<prism:publicationName>Oncogene</prism:publicationName>
<prism:publicationDate>June 22, 2009</prism:publicationDate>
<prism:doi>10.1038/onc.2009.158</prism:doi>
<prism:url>http://dx.doi.org/10.1038/onc.2009.158</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/onc.2009.129">
<title>LKB1 is required for adiponectin-mediated modulation of AMPK&#8211;S6K axis and inhibition of migration and invasion of breast cancer cells</title>
<link>http://dx.doi.org/10.1038/onc.2009.129</link>
<content:encoded><![CDATA[
            
<p>
<b>LKB1 is required for adiponectin-mediated modulation of AMPK&#8211;S6K axis and inhibition of migration and invasion of breast cancer cells</b>
</p>
<p>Oncogene advance online publication, June 1, 2009. <a href="http://dx.doi.org/10.1038/onc.2009.129">doi:10.1038/onc.2009.129</a>
</p>
<p>Authors: L Taliaferro-Smith, A Nagalingam, D Zhong, W Zhou, N K Saxena
                    &amp; D Sharma</p>
]]></content:encoded>
<dc:title>LKB1 is required for adiponectin-mediated modulation of AMPK&#8211;S6K axis and inhibition of migration and invasion of breast cancer cells</dc:title>
<dc:creator>L Taliaferro-Smith</dc:creator>
<dc:creator>A Nagalingam</dc:creator>
<dc:creator>D Zhong</dc:creator>
<dc:creator>W Zhou</dc:creator>
<dc:creator>N K Saxena</dc:creator>
<dc:creator>D Sharma</dc:creator>
<dc:identifier>doi:10.1038/onc.2009.129</dc:identifier>
<dc:source>Oncogene advance online publication, June 1, 2009</dc:source>
<dc:date>2009-06-01</dc:date>
<prism:publicationName>Oncogene</prism:publicationName>
<prism:publicationDate>June 1, 2009</prism:publicationDate>
<prism:doi>10.1038/onc.2009.129</prism:doi>
<prism:url>http://dx.doi.org/10.1038/onc.2009.129</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/onc.2009.162">
<title>WW domain containing E3 ubiquitin protein ligase 1 targets the full-length ErbB4 for ubiquitin-mediated degradation in breast cancer</title>
<link>http://dx.doi.org/10.1038/onc.2009.162</link>
<content:encoded><![CDATA[
            
<p>
<b>WW domain containing E3 ubiquitin protein ligase 1 targets the full-length ErbB4 for ubiquitin-mediated degradation in breast cancer</b>
</p>
<p>Oncogene advance online publication, June 29, 2009. <a href="http://dx.doi.org/10.1038/onc.2009.162">doi:10.1038/onc.2009.162</a>
</p>
<p>Authors: Y Li, Z Zhou, M Alimandi
                    &amp; C Chen</p>
]]></content:encoded>
<dc:title>WW domain containing E3 ubiquitin protein ligase 1 targets the full-length ErbB4 for ubiquitin-mediated degradation in breast cancer</dc:title>
<dc:creator>Y Li</dc:creator>
<dc:creator>Z Zhou</dc:creator>
<dc:creator>M Alimandi</dc:creator>
<dc:creator>C Chen</dc:creator>
<dc:identifier>doi:10.1038/onc.2009.162</dc:identifier>
<dc:source>Oncogene advance online publication, June 29, 2009</dc:source>
<dc:date>2009-06-29</dc:date>
<prism:publicationName>Oncogene</prism:publicationName>
<prism:publicationDate>June 29, 2009</prism:publicationDate>
<prism:doi>10.1038/onc.2009.162</prism:doi>
<prism:url>http://dx.doi.org/10.1038/onc.2009.162</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/onc.2009.122">
<title>DNA methyltransferase-mediated transcriptional silencing in malignant glioma: a combined whole-genome microarray and promoter array analysis</title>
<link>http://dx.doi.org/10.1038/onc.2009.122</link>
<content:encoded><![CDATA[
            
<p>
<b>DNA methyltransferase-mediated transcriptional silencing in malignant glioma: a combined whole-genome microarray and promoter array analysis</b>
</p>
<p>Oncogene advance online publication, May 25, 2009. <a href="http://dx.doi.org/10.1038/onc.2009.122">doi:10.1038/onc.2009.122</a>
</p>
<p>Authors: G Foltz, J -G Yoon, H Lee, T C Ryken, Z Sibenaller, M Ehrich, L Hood
                    &amp; A Madan</p>
]]></content:encoded>
<dc:title>DNA methyltransferase-mediated transcriptional silencing in malignant glioma: a combined whole-genome microarray and promoter array analysis</dc:title>
<dc:creator>G Foltz</dc:creator>
<dc:creator>J -G Yoon</dc:creator>
<dc:creator>H Lee</dc:creator>
<dc:creator>T C Ryken</dc:creator>
<dc:creator>Z Sibenaller</dc:creator>
<dc:creator>M Ehrich</dc:creator>
<dc:creator>L Hood</dc:creator>
<dc:creator>A Madan</dc:creator>
<dc:identifier>doi:10.1038/onc.2009.122</dc:identifier>
<dc:source>Oncogene advance online publication, May 25, 2009</dc:source>
<dc:date>2009-05-25</dc:date>
<prism:publicationName>Oncogene</prism:publicationName>
<prism:publicationDate>May 25, 2009</prism:publicationDate>
<prism:doi>10.1038/onc.2009.122</prism:doi>
<prism:url>http://dx.doi.org/10.1038/onc.2009.122</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/onc.2009.140">
<title>Chromatin remodeling at Alu repeats by epigenetic treatment activates silenced microRNA-512-5p with downregulation of Mcl-1 in human gastric cancer cells</title>
<link>http://dx.doi.org/10.1038/onc.2009.140</link>
<content:encoded><![CDATA[
            
<p>
<b>Chromatin remodeling at Alu repeats by epigenetic treatment activates silenced microRNA-512-5p with downregulation of Mcl-1 in human gastric cancer cells</b>
</p>
<p>Oncogene advance online publication, June 8, 2009. <a href="http://dx.doi.org/10.1038/onc.2009.140">doi:10.1038/onc.2009.140</a>
</p>
<p>Authors: Y Saito, H Suzuki, H Tsugawa, I Nakagawa, J Matsuzaki, Y Kanai
                    &amp; T Hibi</p>
]]></content:encoded>
<dc:title>Chromatin remodeling at Alu repeats by epigenetic treatment activates silenced microRNA-512-5p with downregulation of Mcl-1 in human gastric cancer cells</dc:title>
<dc:creator>Y Saito</dc:creator>
<dc:creator>H Suzuki</dc:creator>
<dc:creator>H Tsugawa</dc:creator>
<dc:creator>I Nakagawa</dc:creator>
<dc:creator>J Matsuzaki</dc:creator>
<dc:creator>Y Kanai</dc:creator>
<dc:creator>T Hibi</dc:creator>
<dc:identifier>doi:10.1038/onc.2009.140</dc:identifier>
<dc:source>Oncogene advance online publication, June 8, 2009</dc:source>
<dc:date>2009-06-08</dc:date>
<prism:publicationName>Oncogene</prism:publicationName>
<prism:publicationDate>June 8, 2009</prism:publicationDate>
<prism:doi>10.1038/onc.2009.140</prism:doi>
<prism:url>http://dx.doi.org/10.1038/onc.2009.140</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/onc.2009.151">
<title>KLF4 suppresses estrogen-dependent breast cancer growth by inhibiting the transcriptional activity of ER&#945;</title>
<link>http://dx.doi.org/10.1038/onc.2009.151</link>
<content:encoded><![CDATA[
            
<p>
<b>KLF4 suppresses estrogen-dependent breast cancer growth by inhibiting the transcriptional activity of ER&#945;</b>
</p>
<p>Oncogene advance online publication, June 8, 2009. <a href="http://dx.doi.org/10.1038/onc.2009.151">doi:10.1038/onc.2009.151</a>
</p>
<p>Authors: K Akaogi, Y Nakajima, I Ito, S Kawasaki, S-h Oie, A Murayama, K Kimura
                    &amp; J Yanagisawa</p>
]]></content:encoded>
<dc:title>KLF4 suppresses estrogen-dependent breast cancer growth by inhibiting the transcriptional activity of ER&#945;</dc:title>
<dc:creator>K Akaogi</dc:creator>
<dc:creator>Y Nakajima</dc:creator>
<dc:creator>I Ito</dc:creator>
<dc:creator>S Kawasaki</dc:creator>
<dc:creator>S-h Oie</dc:creator>
<dc:creator>A Murayama</dc:creator>
<dc:creator>K Kimura</dc:creator>
<dc:creator>J Yanagisawa</dc:creator>
<dc:identifier>doi:10.1038/onc.2009.151</dc:identifier>
<dc:source>Oncogene advance online publication, June 8, 2009</dc:source>
<dc:date>2009-06-08</dc:date>
<prism:publicationName>Oncogene</prism:publicationName>
<prism:publicationDate>June 8, 2009</prism:publicationDate>
<prism:doi>10.1038/onc.2009.151</prism:doi>
<prism:url>http://dx.doi.org/10.1038/onc.2009.151</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/onc.2009.133">
<title>Plexin B1 is repressed by oncogenic B-Raf signaling and functions as a tumor suppressor in melanoma cells</title>
<link>http://dx.doi.org/10.1038/onc.2009.133</link>
<content:encoded><![CDATA[
            
<p>
<b>Plexin B1 is repressed by oncogenic B-Raf signaling and functions as a tumor suppressor in melanoma cells</b>
</p>
<p>Oncogene advance online publication, June 1, 2009. <a href="http://dx.doi.org/10.1038/onc.2009.133">doi:10.1038/onc.2009.133</a>
</p>
<p>Authors: G M Argast, C H Croy, K L Couts, Z Zhang, E Litman, D C Chan
                    &amp; N G Ahn</p>
]]></content:encoded>
<dc:title>Plexin B1 is repressed by oncogenic B-Raf signaling and functions as a tumor suppressor in melanoma cells</dc:title>
<dc:creator>G M Argast</dc:creator>
<dc:creator>C H Croy</dc:creator>
<dc:creator>K L Couts</dc:creator>
<dc:creator>Z Zhang</dc:creator>
<dc:creator>E Litman</dc:creator>
<dc:creator>D C Chan</dc:creator>
<dc:creator>N G Ahn</dc:creator>
<dc:identifier>doi:10.1038/onc.2009.133</dc:identifier>
<dc:source>Oncogene advance online publication, June 1, 2009</dc:source>
<dc:date>2009-06-01</dc:date>
<prism:publicationName>Oncogene</prism:publicationName>
<prism:publicationDate>June 1, 2009</prism:publicationDate>
<prism:doi>10.1038/onc.2009.133</prism:doi>
<prism:url>http://dx.doi.org/10.1038/onc.2009.133</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/onc.2009.126">
<title>GATA3 inhibits breast cancer growth and pulmonary breast cancer metastasis</title>
<link>http://dx.doi.org/10.1038/onc.2009.126</link>
<content:encoded><![CDATA[
            
<p>
<b>GATA3 inhibits breast cancer growth and pulmonary breast cancer metastasis</b>
</p>
<p>Oncogene advance online publication, June 1, 2009. <a href="http://dx.doi.org/10.1038/onc.2009.126">doi:10.1038/onc.2009.126</a>
</p>
<p>Authors: A B Dydensborg, A A N Rose, B J Wilson, D Grote, M Paquet, V Gigu&#232;re, P M Siegel
                    &amp; M Bouchard</p>
]]></content:encoded>
<dc:title>GATA3 inhibits breast cancer growth and pulmonary breast cancer metastasis</dc:title>
<dc:creator>A B Dydensborg</dc:creator>
<dc:creator>A A N Rose</dc:creator>
<dc:creator>B J Wilson</dc:creator>
<dc:creator>D Grote</dc:creator>
<dc:creator>M Paquet</dc:creator>
<dc:creator>V Gigu&#232;re</dc:creator>
<dc:creator>P M Siegel</dc:creator>
<dc:creator>M Bouchard</dc:creator>
<dc:identifier>doi:10.1038/onc.2009.126</dc:identifier>
<dc:source>Oncogene advance online publication, June 1, 2009</dc:source>
<dc:date>2009-06-01</dc:date>
<prism:publicationName>Oncogene</prism:publicationName>
<prism:publicationDate>June 1, 2009</prism:publicationDate>
<prism:doi>10.1038/onc.2009.126</prism:doi>
<prism:url>http://dx.doi.org/10.1038/onc.2009.126</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/onc.2009.104">
<title>Aryl hydrocarbon receptor inhibition downregulates the TGF-&#946;&#47;Smad pathway in human glioblastoma cells</title>
<link>http://dx.doi.org/10.1038/onc.2009.104</link>
<content:encoded><![CDATA[
            
<p>
<b>Aryl hydrocarbon receptor inhibition downregulates the TGF-&#946;&#47;Smad pathway in human glioblastoma cells</b>
</p>
<p>Oncogene advance online publication, May 25, 2009. <a href="http://dx.doi.org/10.1038/onc.2009.104">doi:10.1038/onc.2009.104</a>
</p>
<p>Authors: D Gramatzki, G Pantazis, J Schittenhelm, G Tabatabai, C K&#246;hle, W Wick, M Schwarz, M Weller
                    &amp; I Tritschler</p>
]]></content:encoded>
<dc:title>Aryl hydrocarbon receptor inhibition downregulates the TGF-&#946;&#47;Smad pathway in human glioblastoma cells</dc:title>
<dc:creator>D Gramatzki</dc:creator>
<dc:creator>G Pantazis</dc:creator>
<dc:creator>J Schittenhelm</dc:creator>
<dc:creator>G Tabatabai</dc:creator>
<dc:creator>C K&#246;hle</dc:creator>
<dc:creator>W Wick</dc:creator>
<dc:creator>M Schwarz</dc:creator>
<dc:creator>M Weller</dc:creator>
<dc:creator>I Tritschler</dc:creator>
<dc:identifier>doi:10.1038/onc.2009.104</dc:identifier>
<dc:source>Oncogene advance online publication, May 25, 2009</dc:source>
<dc:date>2009-05-25</dc:date>
<prism:publicationName>Oncogene</prism:publicationName>
<prism:publicationDate>May 25, 2009</prism:publicationDate>
<prism:doi>10.1038/onc.2009.104</prism:doi>
<prism:url>http://dx.doi.org/10.1038/onc.2009.104</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/onc.2009.115">
<title>Expression, regulation and function of the ISGylation system in prostate cancer</title>
<link>http://dx.doi.org/10.1038/onc.2009.115</link>
<content:encoded><![CDATA[
            
<p>
<b>Expression, regulation and function of the ISGylation system in prostate cancer</b>
</p>
<p>Oncogene advance online publication, May 11, 2009. <a href="http://dx.doi.org/10.1038/onc.2009.115">doi:10.1038/onc.2009.115</a>
</p>
<p>Authors: A Kiessling, C Hogrefe, S Erb, C Bobach, S Fuessel, L Wessjohann
                    &amp; B Seliger</p>
]]></content:encoded>
<dc:title>Expression, regulation and function of the ISGylation system in prostate cancer</dc:title>
<dc:creator>A Kiessling</dc:creator>
<dc:creator>C Hogrefe</dc:creator>
<dc:creator>S Erb</dc:creator>
<dc:creator>C Bobach</dc:creator>
<dc:creator>S Fuessel</dc:creator>
<dc:creator>L Wessjohann</dc:creator>
<dc:creator>B Seliger</dc:creator>
<dc:identifier>doi:10.1038/onc.2009.115</dc:identifier>
<dc:source>Oncogene advance online publication, May 11, 2009</dc:source>
<dc:date>2009-05-11</dc:date>
<prism:publicationName>Oncogene</prism:publicationName>
<prism:publicationDate>May 11, 2009</prism:publicationDate>
<prism:doi>10.1038/onc.2009.115</prism:doi>
<prism:url>http://dx.doi.org/10.1038/onc.2009.115</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/onc.2009.144">
<title>Overexpressing PKIB in prostate cancer promotes its aggressiveness by linking between PKA and Akt pathways</title>
<link>http://dx.doi.org/10.1038/onc.2009.144</link>
<content:encoded><![CDATA[
            
<p>
<b>Overexpressing PKIB in prostate cancer promotes its aggressiveness by linking between PKA and Akt pathways</b>
</p>
<p>Oncogene advance online publication, June 1, 2009. <a href="http://dx.doi.org/10.1038/onc.2009.144">doi:10.1038/onc.2009.144</a>
</p>
<p>Authors: S Chung, M Furihata, K Tamura, M Uemura, Y Daigo, Y Nasu, T Miki, T Shuin, T Fujioka, Y Nakamura
                    &amp; H Nakagawa</p>
]]></content:encoded>
<dc:title>Overexpressing PKIB in prostate cancer promotes its aggressiveness by linking between PKA and Akt pathways</dc:title>
<dc:creator>S Chung</dc:creator>
<dc:creator>M Furihata</dc:creator>
<dc:creator>K Tamura</dc:creator>
<dc:creator>M Uemura</dc:creator>
<dc:creator>Y Daigo</dc:creator>
<dc:creator>Y Nasu</dc:creator>
<dc:creator>T Miki</dc:creator>
<dc:creator>T Shuin</dc:creator>
<dc:creator>T Fujioka</dc:creator>
<dc:creator>Y Nakamura</dc:creator>
<dc:creator>H Nakagawa</dc:creator>
<dc:identifier>doi:10.1038/onc.2009.144</dc:identifier>
<dc:source>Oncogene advance online publication, June 1, 2009</dc:source>
<dc:date>2009-06-01</dc:date>
<prism:publicationName>Oncogene</prism:publicationName>
<prism:publicationDate>June 1, 2009</prism:publicationDate>
<prism:doi>10.1038/onc.2009.144</prism:doi>
<prism:url>http://dx.doi.org/10.1038/onc.2009.144</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/onc.2009.137">
<title>Characterization of tumor suppressive function of P300&#47;CBP-associated factor at frequently deleted region 3p24 in esophageal squamous cell carcinoma</title>
<link>http://dx.doi.org/10.1038/onc.2009.137</link>
<content:encoded><![CDATA[
            
<p>
<b>Characterization of tumor suppressive function of P300&#47;CBP-associated factor at frequently deleted region 3p24 in esophageal squamous cell carcinoma</b>
</p>
<p>Oncogene advance online publication, June 15, 2009. <a href="http://dx.doi.org/10.1038/onc.2009.137">doi:10.1038/onc.2009.137</a>
</p>
<p>Authors: C Zhu, Y-R Qin, D Xie, D T T Chua, J M Fung, L Chen, L Fu, L Hu
                    &amp; X-Y Guan</p>
]]></content:encoded>
<dc:title>Characterization of tumor suppressive function of P300&#47;CBP-associated factor at frequently deleted region 3p24 in esophageal squamous cell carcinoma</dc:title>
<dc:creator>C Zhu</dc:creator>
<dc:creator>Y-R Qin</dc:creator>
<dc:creator>D Xie</dc:creator>
<dc:creator>D T T Chua</dc:creator>
<dc:creator>J M Fung</dc:creator>
<dc:creator>L Chen</dc:creator>
<dc:creator>L Fu</dc:creator>
<dc:creator>L Hu</dc:creator>
<dc:creator>X-Y Guan</dc:creator>
<dc:identifier>doi:10.1038/onc.2009.137</dc:identifier>
<dc:source>Oncogene advance online publication, June 15, 2009</dc:source>
<dc:date>2009-06-15</dc:date>
<prism:publicationName>Oncogene</prism:publicationName>
<prism:publicationDate>June 15, 2009</prism:publicationDate>
<prism:doi>10.1038/onc.2009.137</prism:doi>
<prism:url>http://dx.doi.org/10.1038/onc.2009.137</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/onc.2009.155">
<title>SOCS-mediated downregulation of mutant Jak2 (V617F, T875N and K539L) counteracts cytokine-independent signaling</title>
<link>http://dx.doi.org/10.1038/onc.2009.155</link>
<content:encoded><![CDATA[
            
<p>
<b>SOCS-mediated downregulation of mutant Jak2 (V617F, T875N and K539L) counteracts cytokine-independent signaling</b>
</p>
<p>Oncogene advance online publication, June 22, 2009. <a href="http://dx.doi.org/10.1038/onc.2009.155">doi:10.1038/onc.2009.155</a>
</p>
<p>Authors: S Haan, S W&#252;ller, J Kaczor, C Rolvering, T N&#246;cker, I Behrmann
                    &amp; C Haan</p>
]]></content:encoded>
<dc:title>SOCS-mediated downregulation of mutant Jak2 (V617F, T875N and K539L) counteracts cytokine-independent signaling</dc:title>
<dc:creator>S Haan</dc:creator>
<dc:creator>S W&#252;ller</dc:creator>
<dc:creator>J Kaczor</dc:creator>
<dc:creator>C Rolvering</dc:creator>
<dc:creator>T N&#246;cker</dc:creator>
<dc:creator>I Behrmann</dc:creator>
<dc:creator>C Haan</dc:creator>
<dc:identifier>doi:10.1038/onc.2009.155</dc:identifier>
<dc:source>Oncogene advance online publication, June 22, 2009</dc:source>
<dc:date>2009-06-22</dc:date>
<prism:publicationName>Oncogene</prism:publicationName>
<prism:publicationDate>June 22, 2009</prism:publicationDate>
<prism:doi>10.1038/onc.2009.155</prism:doi>
<prism:url>http://dx.doi.org/10.1038/onc.2009.155</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
</rdf:RDF>
